<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus - Valentine, N - 2012 | Cochrane Library</title> <meta property="og:title" content="Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus - Valentine, N - 2012 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005449.pub2/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD005449.pub2" /> <meta name="citation_title" content="Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus" /> <meta name="citation_author" content="Nyoli Valentine" /> <meta name="citation_author_institution" content="Bond University" /> <meta name="citation_author" content="Floris A Van de Laar" /> <meta name="citation_author_institution" content="Radboud University Nijmegen Medical Center" /> <meta name="citation_author_email" content="f.vandelaar@elg.umcn.nl" /> <meta name="citation_author" content="Mieke L van Driel" /> <meta name="citation_author_institution" content="The University of Queensland" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="11" /> <meta name="citation_doi" content="10.1002/14651858.CD005449.pub2" /> <meta name="citation_date" content="2012" /> <meta name="citation_online_date" content="2012/11/14" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005449.pub2/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005449.pub2/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005449.pub2/pdf/CDSR/CD005449/CD005449.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Aspirin [therapeutic use]; Cardiovascular Diseases [*prevention &amp; control]; Clopidogrel; Diabetes Mellitus, Type 2 [*complications]; Dipyridamole [therapeutic use]; Drug Therapy, Combination [methods]; Platelet Aggregation Inhibitors [*therapeutic use]; Purinergic P2Y Receptor Antagonists [*therapeutic use]; Randomized Controlled Trials as Topic; Ticlopidine [analogs &amp; derivatives, therapeutic use]" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1559916431000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717784000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="y8F68iId";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005449\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005449\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","es","ja","fr"],languageCode:"en",accessStatus:"licensed",doi:"10.1002/14651858.CD005449.pub2",title:"Adenosine\\u2010diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus",firstPublishedDate:"Nov 14, 2012 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581423095000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005449.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005449.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD005449.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD005449.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005449.pub2%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD005449.PUB2" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD005449.pub2/#" data-copyright="Copyright © 2012 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005449.pub2/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005449.pub2/full"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-sec1-0006"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/appendices#CD005449-sec1-0012"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/table_n/CD005449StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/table_n/CD005449StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD005449.PUB2"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus </h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD005449-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD005449-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD005449-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD005449-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD005449-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">AAASPS 2003 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0001"> <div class="citation-journal">Gorelick PB, Leurgans S, Richardson J, Harris Y, Billingsley M and the AAASPS Investigators. <span class="citation-title">African American Antiplatelet Stroke Prevention Study: clinical trial design</span>. <span class="citation"> Journal of Stroke and Cerebrovascular Diseases </span><span class="pubYear">1998</span>;<span class="volume">7</span>(6):426‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17895122" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=African+American+Antiplatelet+Stroke+Prevention+Study:+clinical+trial+design&author=PB+Gorelick&author=S+Leurgans&author=J+Richardson&author=Y+Harris&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0002"> <div class="citation-journal">Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y, et al. <span class="citation-title">Aspirin and ticlopidine for prevention of recurrent stroke in black patients</span>. <span class="citation"> JAMA </span><span class="pubYear">2003</span>;<span class="volume">289</span>(22):2947‐57. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12799402" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Aspirin+and+ticlopidine+for+prevention+of+recurrent+stroke+in+black+patients&author=PB+Gorelick&author=D+Richardson&author=M+Kelly&author=S+Ruland&author=E+Hung&author=Y+Harris&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005449-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">CAPRIE 1996 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0003"> <div class="citation-journal">Bhatt DL, Marso SP, Hirsch AT, Tingleb PA, Hacke W, Topol EJ. <span class="citation-title">Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus</span>. <span class="citation"> The American Journal of Cardiology </span><span class="pubYear">2002</span>;<span class="volume">90</span>:625‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12231089" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Amplified+benefit+of+clopidogrel+versus+aspirin+in+patients+with+diabetes+mellitus&author=DL+Bhatt&author=SP+Marso&author=AT+Hirsch&author=PA+Tingleb&author=W+Hacke&author=EJ+Topol&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0004"> <div class="citation-journal">CAPRIE Steering Committee. <span class="citation-title">A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)</span>. <span class="citation"> The Lancet </span><span class="pubYear">1996</span>;<span class="volume">348</span>(9038):1329‐39. <ul class="citation-link-group"> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0005"> <div class="citation-journal">Creager MA. <span class="citation-title">Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events</span>. <span class="citation"> Vascular Medicine </span><span class="pubYear">1998</span>;<span class="volume">3</span>(3):257‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9892520" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Results+of+the+CAPRIE+trial:+efficacy+and+safety+of+clopidogrel.+Clopidogrel+versus+aspirin+in+patients+at+risk+of+ischaemic+events+&author=MA+Creager&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0006"> <div class="citation-journal">Harker LA, Boissel JP, Pilgrim AJ, Gent M. <span class="citation-title">Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events</span>. <span class="citation"> Drug Safety </span><span class="pubYear">1999</span>;<span class="volume">21</span>(4):325‐35. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10514023" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+safety+and+tolerability+of+clopidogrel+and+aspirin:+results+from+CAPRIE.+CAPRIE+Steering+Committee+and+Investigators.+Clopidogrel+versus+aspirin+in+patients+at+risk+of+ischaemic+events+&author=LA+Harker&author=JP+Boissel&author=AJ+Pilgrim&author=M+Gent&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0007"> <div class="citation-journal">Hirsh J, Bhatt DL. <span class="citation-title">Comparative benefits of clopidogrel and aspirin in high‐risk patient populations</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">2004</span>;<span class="volume">164</span>:2106‐10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15505123" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+benefits+of+clopidogrel+and+aspirin+in+high%E2%80%90risk+patient+populations&author=J+Hirsh&author=DL+Bhatt&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005449-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">CATS 1988 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0008"> <div class="citation-journal">Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, et al. <span class="citation-title">The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organisation, and baseline results</span>. <span class="citation"> Stroke </span><span class="pubYear">1988</span>;<span class="volume">19</span>:1203‐10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3051529" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+Canadian+American+Ticlopidine+Study+(CATS)+in+thromboembolic+stroke.+Design,+organisation,+and+baseline+results+&author=M+Gent&author=JA+Blakely&author=JD+Easton&author=DJ+Ellis&author=VC+Hachinski&author=JW+Harbison&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0009"> <div class="citation-journal">Gent M, Easton JD, Hachinski VC, Panak E, Sicurella J, Blakely JA, et al. <span class="citation-title">The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke</span>. <span class="citation"> The Lancet </span><span class="pubYear">1989</span>;<span class="volume">8649</span>:1215‐20. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+Canadian+American+Ticlopidine+Study+(CATS)+in+thromboembolic+stroke&author=M+Gent&author=JD+Easton&author=VC+Hachinski&author=E+Panak&author=J+Sicurella&author=JA+Blakely&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0010"> <div class="citation-journal">Gent M, Ellis D. <span class="citation-title">Canadian American ticlopidine study (cats) in thromboembolic stroke</span>. <span class="citation"> Agents and Actions. Supplements </span><span class="pubYear">1984</span>;<span class="volume">15</span>:283‐96. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6385653" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Canadian+American+ticlopidine+study+(cats)+in+thromboembolic+stroke&author=M+Gent&author=D+Ellis&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005449-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">CHARISMA 2002 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0011"> <div class="citation-journal">Bakhru MR, Bhatt DL. <span class="citation-title">Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin?</span>. <span class="citation"> Cleveland Clinic Journal of Medicine </span><span class="pubYear">2008</span>;<span class="volume">75</span>(4):289‐95. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18491435" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Interpreting+the+CHARISMA+study.+What+is+the+role+of+dual+antiplatelet+therapy+with+clopidogrel+and+aspirin?+&author=MR+Bakhru&author=DL+Bhatt&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0012"> <div class="citation-journal">Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, et al. <span class="citation-title">Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial</span>. <span class="citation"> Journal of the American College of Cardiology </span><span class="pubYear">2007</span>;<span class="volume">49</span>(19):1982‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17498584" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Patients+with+prior+myocardial+infarction,+stroke,+or+symptomatic+peripheral+arterial+disease+in+the+CHARISMA+trial+&author=DL+Bhatt&author=MD+Flather&author=W+Hacke&author=PB+Berger&author=HR+Black&author=WE+Boden&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0013"> <div class="citation-journal">Bhatt DL, Fox KAA, Hacke W, Berger PB, Black HR, for the CHARISMA Investigators. <span class="citation-title">Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">2006</span>;<span class="volume">354</span>(16):1706‐17. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16531616" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clopidogrel+and+aspirin+versus+aspirin+alone+for+the+prevention+of+atherothrombotic+events+&author=DL+Bhatt&author=KAA+Fox&author=W+Hacke&author=PB+Berger&author=HR+Black&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0014"> <div class="citation-journal">Bhatt DL, Topol EJ, on behalf of the CHARISMA Executive Committee. <span class="citation-title">Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high‐risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial</span>. <span class="citation"> American Heart Journal </span><span class="pubYear">2004</span>;<span class="volume">148</span>( 2 ):263‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15308995" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clopidogrel+added+to+aspirin+versus+aspirin+alone+in+secondary+prevention+and+high%E2%80%90risk+primary+prevention:+Rationale+and+design+of+the+Clopidogrel+for+High+Atherothrombotic+Risk+and+Ischemic+Stabilization,+Management,+and+Avoidance+(CHARISMA)+trial+&author=DL+Bhatt&author=EJ+Topol&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0015"> <div class="citation-journal">Collet JP, Montalescot G, Steg PG, Steinhubl SR, Fox KA, Hu TF, et al. <span class="citation-title">Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial</span>. <span class="citation"> Archives of Cardiovascular Diseases </span><span class="pubYear">2009</span>;<span class="volume">102</span>(6‐7):485‐96. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19664568" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+outcomes+according+to+permanent+discontinuation+of+clopidogrel+or+placebo+in+the+CHARISMA+trial+&author=JP+Collet&author=G+Montalescot&author=PG+Steg&author=SR+Steinhubl&author=KA+Fox&author=TF+Hu&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0016"> <div class="citation-journal">Dasgupta A, Steinhubl SR, Bhatt DL, Berger PB, Shao M, for the CHARISMA Investigators. <span class="citation-title">Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischaemic stabilization, management, and avoidance [CHARISMA] trial)</span>. <span class="citation"> American Journal of Cardiology </span><span class="pubYear">2009</span>;<span class="volume">103</span>(10):1359‐63. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19427428" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+outcomes+of+patients+with+diabetic+nephropathy+randomized+to+clopidogrel+plus+aspirin+versus+aspirin+alone+(a+post+hoc+analysis+of+the+clopidogrel+for+high+atherothrombotic+risk+and+ischaemic+stabilization,+management,+and+avoidance+[CHARISMA]+trial)+&author=A+Dasgupta&author=SR+Steinhubl&author=DL+Bhatt&author=PB+Berger&author=M+Shao&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0017"> <div class="citation-journal">Gresele P, Migliacci R. <span class="citation-title">The peripheral arterial disease subgroup in the CHARISMA trial: does it tell us anything new?</span>. <span class="citation"> European Heart Journal </span><span class="pubYear">2009</span>;<span class="volume">30</span>(2):131‐2. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19136485" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+peripheral+arterial+disease+subgroup+in+the+CHARISMA+trial:+does+it+tell+us+anything+new?+&author=P+Gresele&author=R+Migliacci&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0018"> <div class="citation-journal">Hankey GJ, Johnston SC, Easton JD, Hacke W, Mas JL, Brennan D, et al. <span class="citation-title">Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial</span>. <span class="citation"> International Journal of Stroke </span><span class="pubYear">2011</span>;<span class="volume">6</span>(1):3‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21205234" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+clopidogrel+plus+ASA+vs.+ASA+early+after+TIA+and+ischaemic+stroke:+a+substudy+of+the+CHARISMA+trial+&author=GJ+Hankey&author=SC+Johnston&author=JD+Easton&author=W+Hacke&author=JL+Mas&author=D+Brennan&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0019"> <div class="citation-journal">Wang TH, Bhatt DL, Fox KA, Steinhubl SR, Brennan DM, Hacke W, et al. <span class="citation-title">An analysis of mortality rates with dual‐antiplatelet therapy in the primary prevention population of the CHARISMA trial</span>. <span class="citation"> European Heart Journal </span><span class="pubYear">2007</span>;<span class="volume">28</span>(18):2200‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17673448" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=An+analysis+of+mortality+rates+with+dual%E2%80%90antiplatelet+therapy+in+the+primary+prevention+population+of+the+CHARISMA+trial+&author=TH+Wang&author=DL+Bhatt&author=KA+Fox&author=SR+Steinhubl&author=DM+Brennan&author=W+Hacke&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005449-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">CURE 1998 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0020"> <div class="citation-journal">Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, et al. <span class="citation-title">Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non‐ST‐elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial</span>. <span class="citation"> Circulation </span><span class="pubYear">2004</span>;<span class="volume">110</span>(10):1202‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15313956" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Benefits+and+risks+of+the+combination+of+clopidogrel+and+aspirin+in+patients+undergoing+surgical+revascularization+for+non%E2%80%90ST%E2%80%90elevation+acute+coronary+syndrome:+the+Clopidogrel+in+Unstable+angina+to+prevent+Recurrent+ischemic+Events+(CURE)+Trial+&author=KA+Fox&author=SR+Mehta&author=R+Peters&author=F+Zhao&author=N+Lakkis&author=BJ+Gersh&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0021"> <div class="citation-journal">Hirsh J, Bhatt DL. <span class="citation-title">Comparative benefits of clopidogrel and aspirin in high‐risk patient populations: Lessons from the CAPRIE and CURE studies</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">2004</span>;<span class="volume">164</span>(19):2106‐10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15505123" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+benefits+of+clopidogrel+and+aspirin+in+high%E2%80%90risk+patient+populations:+Lessons+from+the+CAPRIE+and+CURE+studies+&author=J+Hirsh&author=DL+Bhatt&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0022"> <div class="citation-journal">Peters RJ, Mehta SR, Fox KA, Zhao F, Lewis BS, Kopecky SL, et al. <span class="citation-title">Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study </span>. <span class="citation"> Circulation </span><span class="pubYear">2003</span>;<span class="volume">108</span>(12):1682‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14504182" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+aspirin+dose+when+used+alone+or+in+combination+with+clopidogrel+in+patients+with+acute+coronary+syndromes:+observations+from+the+Clopidogrel+in+Unstable+angina+to+prevent+Recurrent+Events+(CURE)+study+&author=RJ+Peters&author=SR+Mehta&author=KA+Fox&author=F+Zhao&author=BS+Lewis&author=SL+Kopecky&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0023"> <div class="citation-journal">The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. <span class="citation-title">Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST‐segment elevation</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">2001</span>;<span class="volume">345</span>(7):494‐502. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11519503" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005449-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">Park 2010 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0024"> <div class="citation-journal">Park SJ, Park DW, Kim YH. <span class="citation-title">Duration of dual antiplatelet therapy after implantation of drug‐eluding stents</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">2010</span>;<span class="volume">362</span>(15):1374‐82. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20231231" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Duration+of+dual+antiplatelet+therapy+after+implantation+of+drug%E2%80%90eluding+stents&author=SJ+Park&author=DW+Park&author=YH+Kim&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005449-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">PRoFESS 2008 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0025"> <div class="citation-journal">Bath PM, Cotton D, Martin RH, Palesch Y, Yusuf S, Sacco R, et al. <span class="citation-title">Effect of combined aspirin and extended‐release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis</span>. <span class="citation"> Stroke </span><span class="pubYear">2010</span>;<span class="volume">41</span>(4):732‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20181679" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+combined+aspirin+and+extended%E2%80%90release+dipyridamole+versus+clopidogrel+on+functional+outcome+and+recurrence+in+acute,+mild+ischemic+stroke:+PRoFESS+subgroup+analysis+&author=PM+Bath&author=D+Cotton&author=RH+Martin&author=Y+Palesch&author=S+Yusuf&author=R+Sacco&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0026"> <div class="citation-journal">Diener HC. <span class="citation-title">The PRoFESS trial: future impact on secondary stroke prevention</span>. <span class="citation"> Expert Review of Neurotherapeutics </span><span class="pubYear">2007</span>;<span class="volume">7</span>(9):1085‐91. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17868007" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+PRoFESS+trial:+future+impact+on+secondary+stroke+prevention&author=HC+Diener&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0027"> <div class="citation-journal">Diener HS, Sacco R, Yusuf S, for the Steering Committee and PRoFESS Study Group. <span class="citation-title">Rationale, design and baseline data of a randomized, double‐blind, controlled trial comparing two antithrombotic regimens (a fixed‐dose combination of extended‐release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)</span>. <span class="citation"> Cerebrovascular Diseases </span><span class="pubYear">2007</span>;<span class="volume">23</span>(5‐6):368‐80. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17337887" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rationale,+design+and+baseline+data+of+a+randomized,+double%E2%80%90blind,+controlled+trial+comparing+two+antithrombotic+regimens+(a+fixed%E2%80%90dose+combination+of+extended%E2%80%90release+dipyridamole+plus+ASA+with+clopidogrel)+and+telmisartan+versus+placebo+in+patients+with+strokes:+the+Prevention+Regimen+for+Effectively+Avoiding+Second+Strokes+Trial+(PRoFESS)+&author=HS+Diener&author=R+Sacco&author=S+Yusuf&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0028"> <div class="citation-journal">Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, for the PRoFESS Study Group. <span class="citation-title">Aspirin and extended‐release dipyridamole versus clopidogrel for recurrent stroke</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">2008</span>;<span class="volume">359</span>(12):1238‐51. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18753638" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Aspirin+and+extended%E2%80%90release+dipyridamole+versus+clopidogrel+for+recurrent+stroke&author=RL+Sacco&author=HC+Diener&author=S+Yusuf&author=D+Cotton&author=S+Ounpuu&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005449-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">TASS 1989 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0029"> <div class="citation-journal">Bellavance A. <span class="citation-title">Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The ticlopidine aspirin stroke study</span>. <span class="citation"> Stroke </span><span class="pubYear">1993</span>;<span class="volume">24</span>(10):1452‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8378945" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+ticlopidine+and+aspirin+for+prevention+of+reversible+cerebrovascular+ischemic+events.+The+ticlopidine+aspirin+stroke+study+&author=A+Bellavance&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0030"> <div class="citation-journal">Grutta JC, Norris JW, Kamin B and the TASS Baseline and Angiographic Data Subgroup. <span class="citation-title">Prevention of stroke with ticlopidine: Who benefits most?</span>. <span class="citation"> Neurology </span><span class="pubYear">1992</span>;<span class="volume">42</span>( 1 ):111‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prevention+of+stroke+with+ticlopidine:+Who+benefits+most?&author=JC+Grutta&author=JW+Norris&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0031"> <div class="citation-journal">Harbison JW. <span class="citation-title">Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the ticlopidine aspirin stroke study</span>. <span class="citation"> Stroke </span><span class="pubYear">1992</span>;<span class="volume">23</span>(12):1723‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1448821" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ticlopidine+versus+aspirin+for+the+prevention+of+recurrent+stroke.+Analysis+of+patients+with+minor+stroke+from+the+ticlopidine+aspirin+stroke+study+&author=JW+Harbison&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0032"> <div class="citation-journal">Hass WK, Easton J, Adams HP, Pryse‐Phillips W, Molony BA, for the Ticlopidine Aspirin Stroke Study Group. <span class="citation-title">A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high‐risk patients</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">1989</span>;<span class="volume">321</span>(8):501‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2761587" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+comparing+ticlopidine+hydrochloride+with+aspirin+for+the+prevention+of+stroke+in+high%E2%80%90risk+patients+&author=WK+Hass&author=J+Easton&author=HP+Adams&author=W+Pryse%E2%80%90Phillips&author=BA+Molony&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0033"> <div class="citation-journal">Pryse‐Phillips WAU, for the TASS Group. <span class="citation-title">Ticlopidine aspirin stroke study: outcome by vascular distribution of the qualifying event</span>. <span class="citation"> Journal of Stroke and Cerebrovascular Diseases </span><span class="pubYear">1993</span>;<span class="volume">3</span>:49‐56. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/26487077" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ticlopidine+aspirin+stroke+study:+outcome+by+vascular+distribution+of+the+qualifying+event+&author=WAU+Pryse%E2%80%90Phillips&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0034"> <div class="citation-journal">Ticlopidine Aspirin Stroke Study Group. <span class="citation-title">Ticlopidine versus aspirin for stroke prevention: on‐treatment results from the ticlopidine aspirin stroke study</span>. <span class="citation"> Journal of Stroke and Cerebrovascular Diseases </span><span class="pubYear">1993</span>;<span class="volume">3</span>:168‐76. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/26487357" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005449-bib-0035"> <div class="citation-journal">Weisberg LA. <span class="citation-title">The efficacy and safety of ticlopidine and aspirin in non‐whites: analysis of a patient subgroup from the ticlopidine aspirin stroke study</span>. <span class="citation"> Neurology </span><span class="pubYear">1993</span>;<span class="volume">43</span>(1):27‐31. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8423906" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+efficacy+and+safety+of+ticlopidine+and+aspirin+in+non%E2%80%90whites:+analysis+of+a+patient+subgroup+from+the+ticlopidine+aspirin+stroke+study+&author=LA+Weisberg&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD005449-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD005449-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD005449-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD005449-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Balsano 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0036"> <div class="citation-journal">Balsano F, Rizzon P, Violi F, Scrutinio D, Cimminiello C, Aguglia F, et al. <span class="citation-title">Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial</span>. <span class="citation"> Circulation </span><span class="pubYear">1990</span>;<span class="volume">82</span>(1):17‐26. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2194694" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antiplatelet+treatment+with+ticlopidine+in+unstable+angina.+A+controlled+multicenter+clinical+trial+&author=F+Balsano&author=P+Rizzon&author=F+Violi&author=D+Scrutinio&author=C+Cimminiello&author=F+Aguglia&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">CHANCE 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0037"> <div class="citation-journal">Wang Y, Johnston SC, for the CHANCE investigators. <span class="citation-title">Rationale and design of a randomized, double‐blind trial comparing the effects of a 3‐month clopidogrel‐aspirin regimen versus aspirin alone for the treatment of high‐risk patients with acute nondisabling cerebrovascular event</span>. <span class="citation"> American Heart Journal </span><span class="pubYear">2010</span>;<span class="volume">160</span>(3):380‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20826243" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rationale+and+design+of+a+randomized,+double%E2%80%90blind+trial+comparing+the+effects+of+a+3%E2%80%90month+clopidogrel%E2%80%90aspirin+regimen+versus+aspirin+alone+for+the+treatment+of+high%E2%80%90risk+patients+with+acute+nondisabling+cerebrovascular+event+&author=Y+Wang&author=SC+Johnston&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">CLARITY 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0038"> <div class="citation-journal">Sabatine MS, Cannon CP, Gibson CM, López‐Sendón JL, Montalescot G, Theroux P, et al. <span class="citation-title">Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST‐elevation myocardial infarction treated with fibrinolytics: the PCI‐CLARITY study</span>. <span class="citation"> JAMA </span><span class="pubYear">2005</span>;<span class="volume">294</span>(10):1224‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16143698" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+clopidogrel+pretreatment+before+percutaneous+coronary+intervention+in+patients+with+ST%E2%80%90elevation+myocardial+infarction+treated+with+fibrinolytics:+the+PCI%E2%80%90CLARITY+study+&author=MS+Sabatine&author=CP+Cannon&author=CM+Gibson&author=JL+L%C3%B3pez%E2%80%90Send%C3%B3n&author=G+Montalescot&author=P+Theroux&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">COMMIT 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0039"> <div class="citation-journal">Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, et al. <span class="citation-title">Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo‐controlled trial</span>. <span class="citation"> The Lancet </span><span class="pubYear">2005</span>;<span class="volume">366</span>(9497):1607‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+clopidogrel+to+aspirin+in+45,852+patients+with+acute+myocardial+infarction:+randomised+placebo%E2%80%90controlled+trial+&author=ZM+Chen&author=LX+Jiang&author=YP+Chen&author=JX+Xie&author=HC+Pan&author=R+Peto&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">CREDO 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0040"> <div class="citation-journal">Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C, et al. <span class="citation-title">Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial</span>. <span class="citation"> JAMA </span><span class="pubYear">2002</span>;<span class="volume">288</span>(19):2411‐20. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12435254" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Early+and+sustained+dual+oral+antiplatelet+therapy+following+percutaneous+coronary+intervention:+a+randomized+controlled+trial+&author=SR+Steinhubl&author=PB+Berger&author=JT+Mann&author=ET+Fry&author=A+DeLago&author=C+Wilmer&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Cun 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0041"> <div class="citation-journal">Cun VG, Temuzhan A, Pekdemur H, Toka M, Tartanoglu O. <span class="citation-title">The effects of ticlopidine in acute myocardial infarction as an adjunctive treatment to aspirin in an intermediate term setting</span>. <span class="citation"> Turkish Journal of Medical Sciences </span><span class="pubYear">2002</span>;<span class="volume">32</span>(4):329‐34. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+ticlopidine+in+acute+myocardial+infarction+as+an+adjunctive+treatment+to+aspirin+in+an+intermediate+term+setting+&author=VG+Cun&author=A+Temuzhan&author=H+Pekdemur&author=M+Toka&author=O+Tartanoglu&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Harrington 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0042"> <div class="citation-journal">Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, et al. <span class="citation-title">Platelet inhibition with cangrelor in patients undergoing PCI</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">2009</span>;<span class="volume">361</span>(24):2318‐29. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19915221" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Platelet+inhibition+with+cangrelor+in+patients+undergoing+PCI&author=RA+Harrington&author=GW+Stone&author=S+McNulty&author=HD+White&author=AM+Lincoff&author=CM+Gibson&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Ishikawa 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0043"> <div class="citation-journal">Ishikawa K, Kanamasa K, Hama J, Ogawa I, Takenaka T, Naito T, et al. <span class="citation-title">Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention Group</span>. <span class="citation"> Japanese Circulation Journal </span><span class="pubYear">1997</span>;<span class="volume">61</span>(1):38‐45. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9070958" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Aspirin+plus+either+dipyridamole+or+ticlopidine+is+effective+in+preventing+recurrent+myocardial+infarction.+Secondary+Prevention+Group+&author=K+Ishikawa&author=K+Kanamasa&author=J+Hama&author=I+Ogawa&author=T+Takenaka&author=T+Naito&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">JUMBO TIMI 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0044"> <div class="citation-journal">Wiviott SD, Antman EM, Winters KJ, Weerakkody G, Murphy SA, Behounek BD, et al. <span class="citation-title">Randomized comparison of prasugrel (CS‐747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)‐TIMI 26 trial</span>. <span class="citation"> Circulation </span><span class="pubYear">2005</span>;<span class="volume">111</span>(25):3366‐73. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15967851" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomized+comparison+of+prasugrel+(CS%E2%80%90747,+LY640315),+a+novel+thienopyridine+P2Y12+antagonist,+with+clopidogrel+in+percutaneous+coronary+intervention:+results+of+the+Joint+Utilization+of+Medications+to+Block+Platelets+Optimally+(JUMBO)%E2%80%90TIMI+26+trial+&author=SD+Wiviott&author=EM+Antman&author=KJ+Winters&author=G+Weerakkody&author=SA+Murphy&author=BD+Behounek&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">Li 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0045"> <div class="citation-journal">Li YZ, Wang L, Yu PX. <span class="citation-title">A randomized trial comparing ticlopidine with aspirin for the prevention of ischaemic cerebral stroke</span>. <span class="citation"> Acta Pharmacologica Sinica </span><span class="pubYear">1999</span>;<span class="volume">20</span>(5):476. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+comparing+ticlopidine+with+aspirin+for+the+prevention+of+ischaemic+cerebral+stroke+&author=YZ+Li&author=L+Wang&author=PX+Yu&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Machraoui 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0046"> <div class="citation-journal">Machraoui A, Germing A, Lindstaedt M, Dryander S, Bojara W, Lawo T, et al. <span class="citation-title">Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: follow‐up results of a randomized study</span>. <span class="citation"> Journal of Invasive Cardiology </span><span class="pubYear">June 2001</span>;<span class="volume">13</span>(6):431‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11385163" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+ticlopidine+monotherapy+versus+ticlopidine+and+aspirin+after+coronary+artery+stenting:+follow%E2%80%90up+results+of+a+randomized+study+&author=A+Machraoui&author=A+Germing&author=M+Lindstaedt&author=S+Dryander&author=W+Bojara&author=T+Lawo&publication_year=June2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">MATCH 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0047"> <div class="citation-journal">Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. <span class="citation-title">Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high‐risk patients (MATCH): randomised, double‐blind, placebo‐controlled trial</span>. <span class="citation"> The Lancet </span><span class="pubYear">2004</span>;<span class="volume">364</span>(9431):331‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Aspirin+and+clopidogrel+compared+with+clopidogrel+alone+after+recent+ischaemic+stroke+or+transient+ischaemic+attack+in+high%E2%80%90risk+patients+(MATCH):+randomised,+double%E2%80%90blind,+placebo%E2%80%90controlled+trial+&author=HC+Diener&author=J+Bogousslavsky&author=LM+Brass&author=C+Cimminiello&author=L+Csiba&author=M+Kaste&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Mueller 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0048"> <div class="citation-journal">Mueller C, Roskamm H, Neumann FJ, Hunziker P, Marsch S, Perruchoud A, et al. <span class="citation-title">A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents</span>. <span class="citation"> Journal of the American College of Cardiology </span><span class="pubYear">2003</span>;<span class="volume">41</span>(6):969‐73. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12651043" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+comparison+of+clopidogrel+and+aspirin+versus+ticlopidine+and+aspirin+after+the+placement+of+coronary+artery+stents+&author=C+Mueller&author=H+Roskamm&author=FJ+Neumann&author=P+Hunziker&author=S+Marsch&author=A+Perruchoud&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">PLATO 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0049"> <div class="citation-journal">Wallentin L, Becker RC, Budaj A, Cannon C, for the PLATO investigators. <span class="citation-title">Ticagrelor versus clopidogrel in patients with acute coronary syndromes</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">2009</span>;<span class="volume">361</span>(11):1045‐57. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19717846" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ticagrelor+versus+clopidogrel+in+patients+with+acute+coronary+syndromes&author=L+Wallentin&author=RC+Becker&author=A+Budaj&author=C+Cannon&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">STAMI 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0050"> <div class="citation-journal">Scrutinio D, Cimminiello C, Marubini E, Pitzalis MV, Biase M, Rizzon P. <span class="citation-title">Ticlopidine versus aspirin after myocardial infarction (STAMI) trial</span>. <span class="citation"> Journal of American College of Cardiology </span><span class="pubYear">2001</span>;<span class="volume">37</span>(5):1259‐65. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ticlopidine+versus+aspirin+after+myocardial+infarction+(STAMI)+trial&author=D+Scrutinio&author=C+Cimminiello&author=E+Marubini&author=MV+Pitzalis&author=M+Biase&author=P+Rizzon&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">STIMS 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0051"> <div class="citation-journal">Janzon L, Berggvist D, Boberg J, Boberg M, Eriksson I, Lindgarde F, et al. <span class="citation-title">Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study</span>. <span class="citation"> Journal of Internal Medicine </span><span class="pubYear">1990</span>;<span class="volume">227</span>(5):301‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2187948" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prevention+of+myocardial+infarction+and+stroke+in+patients+with+intermittent+claudication;+effects+of+ticlopidine.+Results+from+STIMS,+the+Swedish+Ticlopidine+Multicentre+Study+&author=L+Janzon&author=D+Berggvist&author=J+Boberg&author=M+Boberg&author=I+Eriksson&author=F+Lindgarde&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">TISS 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0052"> <div class="citation-journal">Bergamasco B, Benna P, Carolei A, Rasura M, Rudelli G, Fieschi C. <span class="citation-title">A randomized trial comparing ticlopidine hydrochloride with ibuprofen for the prevention of stroke in high‐risk patients (TISS Study). Ticlopidine Indobufen Stroke Study</span>. <span class="citation"> Functional Neurology </span><span class="pubYear">1997</span>;<span class="volume">12</span>(1):33‐43. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9127122" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+comparing+ticlopidine+hydrochloride+with+ibuprofen+for+the+prevention+of+stroke+in+high%E2%80%90risk+patients+(TISS+Study).+Ticlopidine+Indobufen+Stroke+Study+&author=B+Bergamasco&author=P+Benna&author=A+Carolei&author=M+Rasura&author=G+Rudelli&author=C+Fieschi&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Tohgi 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0053"> <div class="citation-journal">Tohgi H, Murakami M. <span class="citation-title">The effect of ticlopidine on TIA compared with aspirin ‐ a double‐blind, twelve‐month and open 24 month follow up study</span>. <span class="citation"> Japanese Journal of Medicine </span><span class="pubYear">1987</span>;<span class="volume">26</span>(1):117‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+ticlopidine+on+TIA+compared+with+aspirin+%E2%80%90+a+double%E2%80%90blind,+twelve%E2%80%90month+and+open+24+month+follow+up+study+&author=H+Tohgi&author=M+Murakami&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">TOPALS 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0054"> <div class="citation-journal">Ito E, Takahashi A, Yamamoto H, Kuzuhara S, Uchiyama S, Nakajima M. <span class="citation-title">Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke (the Tokai Panaldine Aspirin Long‐term Study (TOPALS))</span>. <span class="citation"> Internal Medicine </span><span class="pubYear">2003</span>;<span class="volume">42</span>(9):793‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14518664" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ticlopidine+alone+versus+ticlopidine+plus+aspirin+for+preventing+recurrent+stroke+(the+Tokai+Panaldine+Aspirin+Long%E2%80%90term+Study+(TOPALS))+&author=E+Ito&author=A+Takahashi&author=H+Yamamoto&author=S+Kuzuhara&author=S+Uchiyama&author=M+Nakajima&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005449-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">TRITON‐TIMI 38 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0055"> <div class="citation-journal">Wivott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. <span class="citation-title">Prasugrel versus clopidogrel in patients with acute coronary syndromes</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">2007</span>;<span class="volume">357</span>(20):2001‐15. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17982182" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prasugrel+versus+clopidogrel+in+patients+with+acute+coronary+syndromes&author=SD+Wivott&author=E+Braunwald&author=CH+McCabe&author=G+Montalescot&author=W+Ruzyllo&author=S+Gottlieb&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD005449-bbs1-0003"> <h3 class="title">References to ongoing studies</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD005449-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD005449-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD005449-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD005449-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">SPS3 2011 {published data only} </h4> </div> <div class="bibliography-section" id="CD005449-bib-0056"> <div class="citation-journal">Benavente OR, White CL, Pearce L, Pergola P, Roldan A, Benavente MF, and the SPS3 Investigators. <span class="citation-title">The secondary prevention of small subcortical strokes (SPS3) study</span>. <span class="citation"> International Journal of Stroke </span><span class="pubYear">April 2011</span>;<span class="volume">6</span>(2):164‐75. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21371282" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+secondary+prevention+of+small+subcortical+strokes+(SPS3)+study&author=OR+Benavente&author=CL+White&author=L+Pearce&author=P+Pergola&author=A+Roldan&author=MF+Benavente&publication_year=April2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD005449-bbs1-0004"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD005449-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD005449-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD005449-bbs1-0003">ongoing studies</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">ADA 1997</h4> </div> <div class="bibliography-section" id="CD005449-bib-0057"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Report of the Expert Committee on the diagnosis and classification of diabetes mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>(7):1183‐97. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9203460" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">ADA 1999</h4> </div> <div class="bibliography-section" id="CD005449-bib-0058"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">The Expert Committee on the diagnosis and classification of diabetes mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(Suppl 1):S1‐114. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10333970" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">ADA 2011</h4> </div> <div class="bibliography-section" id="CD005449-bib-0059"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Standards of medical care in diabetes‐2011</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2011</span>;<span class="volume">34</span>(Suppl 1):s11‐61. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21193625" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Angiolillo 2009</h4> </div> <div class="bibliography-section" id="CD005449-bib-0060"> <div class="citation-journal">Angiolillo DJ, Suryadevara S. <span class="citation-title">Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus</span>. <span class="citation"> Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism </span><span class="pubYear">2009 Jun</span>;<span class="volume">23</span>(3):375‐88. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19520310" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Aspirin+and+clopidogrel:+efficacy+and+resistance+in+diabetes+mellitus&author=DJ+Angiolillo&author=S+Suryadevara&publication_year=2009Jun&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Antithrombotic Trialists' Collaboration 2002</h4> </div> <div class="bibliography-section" id="CD005449-bib-0061"> <div class="citation-journal">Antithrombotic Trialists' Collaboration. <span class="citation-title">Collaborative meta‐analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients</span>. <span class="citation"> BMJ </span><span class="pubYear">2002</span>;<span class="volume">324</span>(7329):71‐86. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11786451" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Bhatt 2002</h4> </div> <div class="bibliography-section" id="CD005449-bib-0062"> <div class="citation-journal">Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. <span class="citation-title">Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus</span>. <span class="citation"> American Journal of Cardiology </span><span class="pubYear">2002</span>;<span class="volume">90</span>(6):625‐8. [MEDLINE: 2] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12231089" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Amplified+benefit+of+clopidogrel+versus+aspirin+in+patients+with+diabetes+mellitus&author=DL+Bhatt&author=SP+Marso&author=AT+Hirsch&author=PA+Ringleb&author=W+Hacke&author=EJ+Topol&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Ceriello 2004</h4> </div> <div class="bibliography-section" id="CD005449-bib-0063"> <div class="citation-journal">Ceriello A, Motz E. <span class="citation-title">Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited</span>. <span class="citation"> Arteriosclerosis, thrombosis, and vascular biology 1: Arteriosclerosis, thrombosis, and vascular biology </span><span class="pubYear">2004</span>;<span class="volume">24</span>(5):816‐23. [MEDLINE: 26] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Is+oxidative+stress+the+pathogenic+mechanism+underlying+insulin+resistance,+diabetes,+and+cardiovascular+disease?+The+common+soil+hypothesis+revisited+&author=A+Ceriello&author=E+Motz&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Colwell 2003</h4> </div> <div class="bibliography-section" id="CD005449-bib-0064"> <div class="citation-journal">Colwell JA. <span class="citation-title">Aspirin for primary prevention of cardiovascular events in diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(12):3349‐50. [MEDLINE: 16] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14633827" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Aspirin+for+primary+prevention+of+cardiovascular+events+in+diabetes&author=JA+Colwell&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Goodwin 2011</h4> </div> <div class="bibliography-section" id="CD005449-bib-0065"> <div class="citation-journal">Goodwin MM, Desilets AR, Willett KC. <span class="citation-title">Thienopyridines in acute coronary syndrome</span>. <span class="citation"> The Annals of Pharmacotherapy </span><span class="pubYear">2011</span>;<span class="volume">45</span>(2):207‐17. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21304037" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thienopyridines+in+acute+coronary+syndrome&author=MM+Goodwin&author=AR+Desilets&author=KC+Willett&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Gu 1998</h4> </div> <div class="bibliography-section" id="CD005449-bib-0066"> <div class="citation-journal">Gu K, Cowie CC, Harris MI. <span class="citation-title">Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971‐1993</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(7):1138‐45. [MEDLINE: 24] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9653609" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Mortality+in+adults+with+and+without+diabetes+in+a+national+cohort+of+the+U.S.+population,+1971%E2%80%901993+&author=K+Gu&author=CC+Cowie&author=MI+Harris&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Haffner 1998</h4> </div> <div class="bibliography-section" id="CD005449-bib-0067"> <div class="citation-journal">Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. <span class="citation-title">Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1998</span>;<span class="volume">339</span>(4):229‐34. [MEDLINE: 25] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9673301" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Mortality+from+coronary+heart+disease+in+subjects+with+type+2+diabetes+and+in+nondiabetic+subjects+with+and+without+prior+myocardial+infarction+&author=SM+Haffner&author=S+Lehto&author=T+Ronnemaa&author=K+Pyorala&author=M+Laakso&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">Higgins 2002</h4> </div> <div class="bibliography-section" id="CD005449-bib-0068"> <div class="citation-journal">Higgins JP, Thompson SG. <span class="citation-title">Quantifying heterogeneity in a meta‐analysis</span>. <span class="citation"> Statistics in Medicine </span><span class="pubYear">2002</span>;<span class="volume">21</span>(11):1539‐58. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12111919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Quantifying+heterogeneity+in+a+meta%E2%80%90analysis&author=JP+Higgins&author=SG+Thompson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD005449-bib-0069"> <div class="citation-journal">Higgins JPT, Thompson SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analysis</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>:557‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analysis&author=JPT+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">Higgins 2011</h4> </div> <div class="bibliography-section" id="CD005449-bib-0070"> <div class="citation-other">Higgins JPT, Green S (editors). <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</span>. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Kam 2003</h4> </div> <div class="bibliography-section" id="CD005449-bib-0071"> <div class="citation-journal">Kam, CA, Nethery, CM. <span class="citation-title">The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and developments</span>. <span class="citation"> Anaesthesia </span><span class="pubYear">2003</span>;<span class="volume">58</span>(1):28‐35. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12492666" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+thienopyridine+derivatives+(platelet+adenosine+diphosphate+receptor+antagonists),+pharmacology+and+developments+&author=+Kam&author=+CA&author=+Nethery&author=+CM&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Kutti 1986</h4> </div> <div class="bibliography-section" id="CD005449-bib-0072"> <div class="citation-journal">Kutti J, Wadenvik H, Henestam B, Stenstrom G. <span class="citation-title">Evaluation of platelet reactivity in diabetes mellitus</span>. <span class="citation"> Acta Medica Scandinavica </span><span class="pubYear">1986</span>;<span class="volume">219</span>(2):195‐9. [MEDLINE: 28] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2938425" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Evaluation+of+platelet+reactivity+in+diabetes+mellitus&author=J+Kutti&author=H+Wadenvik&author=B+Henestam&author=G+Stenstrom&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Lau 2006</h4> </div> <div class="bibliography-section" id="CD005449-bib-0073"> <div class="citation-journal">Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. <span class="citation-title">The case of the misleading funnel plot</span>. <span class="citation"> BMJ </span><span class="pubYear">2006</span>;<span class="volume">333</span>:597‐600. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16974018" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+case+of+the+misleading+funnel+plot&author=J+Lau&author=JPA+Ioannidis&author=N+Terrin&author=CH+Schmid&author=I+Olkin&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">Liberati 2009</h4> </div> <div class="bibliography-section" id="CD005449-bib-0074"> <div class="citation-journal">Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. <span class="citation-title">The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration</span>. <span class="citation"> PLoS Medicine </span><span class="pubYear">1999</span>;<span class="volume">6</span>(7):1‐28. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1371/journal.pmed.1000100" target="_blank"><span>10.1371/journal.pmed.1000100</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+PRISMA+statement+for+reporting+systematic+and+meta%E2%80%90analyses+of+studies+that+evaluate+interventions:+explanation+and+elaboration+&author=A+Liberati&author=DG+Altman&author=J+Tetzlaff&author=C+Mulrow&author=PC+G%C3%B8tzsche&author=JPA+Ioannidis&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">NICE 2010</h4> </div> <div class="bibliography-section" id="CD005449-bib-0075"> <div class="citation-other">National Insitute for Health and Clinical Excellence. <span class="citation-title">Unstable angina and NSTEMI. The early management of unstable angina and non‐ST‐segment‐elevation myocardial infarction. Clinical guideline 94</span>. http://guidance.nice.org.uk/CG94/NICEGuidance/pdf/English (accessed March 2010). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Squizzato 2011</h4> </div> <div class="bibliography-section" id="CD005449-bib-0076"> <div class="citation-journal">Squizzato A, Keller T, Romualdi E, Middeldorp S. <span class="citation-title">Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2011</span>, Issue 1. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD005158.pub3" target="_blank"><span>10.1002/14651858.CD005158.pub3</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clopidogrel+plus+aspirin+versus+aspirin+alone+for+preventing+cardiovascular+disease&author=A+Squizzato&author=T+Keller&author=E+Romualdi&author=S+Middeldorp&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Sterne 2001</h4> </div> <div class="bibliography-section" id="CD005449-bib-0077"> <div class="citation-book">Sterne JAC, Egger M, Davey Smith G. <span class="citation-title">Investigating and dealing with publication and other biases</span>. In: Egger M, Davey Smith G, Altman DG editor(s). <span class="citation">Systematic Reviews in Health Care; Meta‐analysis in Context</span>. London: BMJ Publishing Group, <span class="pubYear">2001</span>:189‐208. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Investigating+and+dealing+with+publication+and+other+biases&author=JAC+Sterne&author=M+Egger&author=G+DaveySmith&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Sudlow 2009</h4> </div> <div class="bibliography-section" id="CD005449-bib-0078"> <div class="citation-journal">Sudlow CLM, Mason G, Maurice JB, Wedderburn CJ, Hankey GJ. <span class="citation-title">Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2009</span>, Issue 4. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD001246.pub2" target="_blank"><span>10.1002/14651858.CD001246.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19821273" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thienopyridine+derivatives+versus+aspirin+for+preventing+stroke+and+other+serious+vascular+events+in+high+vascular+risk+patients+&author=CLM+Sudlow&author=G+Mason&author=JB+Maurice&author=CJ+Wedderburn&author=GJ+Hankey&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">WHO 1980</h4> </div> <div class="bibliography-section" id="CD005449-bib-0079"> <div class="citation-other">WHO Expert Committee on Diabetes Mellitus. <span class="citation-title">Second report</span>. World Health Organisation: Technical Report Series 646; 1980. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">WHO 1985</h4> </div> <div class="bibliography-section" id="CD005449-bib-0080"> <div class="citation-other">World Health Organisation. <span class="citation-title">Diabetes Mellitus: Report of a WHO Study Group</span>. World Health Organisation: Technical Report Series No. 727; 1985. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">WHO 1998</h4> </div> <div class="bibliography-section" id="CD005449-bib-0081"> <div class="citation-journal">Alberti KM, Zimmet PZ. <span class="citation-title">Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>(7):539‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9686693" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Definition,+diagnosis+and+classification+of+diabetes+mellitus+and+its+complications.+Part+I:+diagnosis+and+classification+of+diabetes+mellitus.+Provisional+report+of+a+WHO+consultation+&author=KM+Alberti&author=PZ+Zimmet&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005449-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Wild 2004</h4> </div> <div class="bibliography-section" id="CD005449-bib-0082"> <div class="citation-journal">Wild S, Roglic G, Green A, Sicree R, King H. <span class="citation-title">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>(5):1047‐53. [MEDLINE: 23] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15111519" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Global+prevalence+of+diabetes:+estimates+for+the+year+2000+and+projections+for+2030&author=S+Wild&author=G+Roglic&author=A+Green&author=R+Sicree&author=H+King&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD005449-sec2-0022"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD005449-sec2-0023" class="jump-to">excluded studies</a></li> <li><a href="#CD005449-sec2-0024" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">AAASPS 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL, RANDOMISATION RATIO: 1:1, EQUIVALENCE DESIGN</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INCLUSION CRITERIA</b>: </p> <p>African American <br> 29 to 85 years of age <br> Non‐cardioembolic cerebral infarct <br> Cerebral infarct 7 to 90 days prior </p> <p>CT or MRI consistent with occurrence of entry cerebral infarct (shows entry infarct, old infarct, or no infarct) <br> Measurable neurological deficit that correlates with onset of entry cerebral infarct <br> Able to follow an outpatient treatment program </p> <p><b>EXCLUSION CRITERIA</b>: </p> <p>Transient ischaemic attack</p> <p>Subarachnoid haemorrhage</p> <p>Cardiac embolism</p> <p>Iatrogenic stroke</p> <p>Postoperative stroke within 30 days of operation</p> <p>Carotid endarterectomy as preventive treatment of entry cerebral infarct <br> Mean arterial blood pressure &gt; 130 mm Hg on 3 consecutive days <br> Modified Barthel Index &lt; 10 <br> History of dementia or neurodegenerative disease <br> Severe comorbid condition such as cancer that would limit survival during 2‐year follow‐up period <br> Concurrent enrolment in another clinical trial <br> Sensitivity or allergy to aspirin or ticlopidine <br> Women of childbearing potential <br> Peptic ulcer disease, active bleeding diathesis, lower gastrointestinal bleeding, platelet or other haematologic abnormality clinically active in the past year <br> Haematuria </p> <p>Positive stool guaiac</p> <p>Prolonged prothrombin time or partial thromboplastin time</p> <p>Blood urea nitrogen &gt; 40 mg %,</p> <p>Serum creatinine &gt; 2.0 mg %</p> <p>Thrombocytopenia or neutropenia as defined by the lower limit of normal for the platelet count or white blood cell count </p> <p>≥ 2 times the upper range of normal on liver function tests</p> <p><b>PARTICIPANTS</b>: </p> <p>Total participants: 1809 (Aspirin: 907, Ticlodipine: 902)</p> <p>Diabetes participants: 738 (Aspirin: 379, Ticlodipine: 359)</p> <p>Total participants withdrawn or prematurely discontinuing study medication: 454 (Aspirin: 215, Ticlodipine: 239) </p> <p>Total participants lost to follow‐up: 68 (Aspirin: 31, Ticlodipine: 37)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INTERVENTION</b>: Ticlopidine 250 mg twice daily and placebo </p> <p><b>CONTROL</b>: Aspirin 325 mg twice daily and placebo </p> <p><b>NUMBER OF STUDY CENTRES</b>: 62 </p> <p><b>COUNTRY/ LOCATION</b>: United States of America </p> <p><b>SETTING</b>: Hospital and community </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>OUTCOMES</b><i>(as documented in the published protocol):</i> </p> <p>Composite endpoint of myocardial infarction, recurrent stroke and vascular death</p> <p>All cause mortality patients with diabetes: unknown</p> <p>All cause mortality all patients: Aspirin: 40, Ticlopidine: 45</p> <p>Vascular mortality patients with diabetes: unknown</p> <p>Vascular mortality all patients: Aspirin:18, Ticlopidine: 18</p> <p>Myocardial infarction patients with diabetes (fatal): unknown</p> <p>Myocardial infarction patients with diabetes (non‐fatal): unknown</p> <p>Myocardial infarction all patients (fatal): Aspirin: 0, Ticlopidine: 1</p> <p>Myocardial infarction all patients (non‐fatal): Aspirin: 8, Ticlopidine: 8</p> <p>Stroke patients with diabetes (fatal): unknown</p> <p>Stroke patients with diabetes (non‐fatal): unknown</p> <p>Stroke all patients (fatal): Aspirin: 2, Ticlopidine: 4</p> <p>Stroke all patients (non‐fatal): Aspirin: 84, Ticlopidine: 102</p> <p>Serious adverse event patients with diabetes: unknown</p> <p>Serious adverse event all patients: Aspirin: 262, Ticlopidine: 270</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RUN‐IN PERIOD</b>: None </p> <p><b>STUDY TERMINATED BEFORE REGULAR END</b>: Yes ‐ at 6.5 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b> </p> <p><b>PUBLICATION STATUS: PEER REVIEW JOURNAL</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>"the primary hypothesis of this ... trial ... is that ticlopidine hydrochloride is more effective than aspirin in preventing the composite endpoints of recurrent stroke, myocardial infarction, and vascular death among middle‐aged and elderly African Americans with non‐cardioembolic ischemic stroke" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Supported by the National Institute of Neurological Disorders and Stroke. Medications and placebos were supplied by Roche Laboratories and Bayer </p> <p><b>Abbreviations</b>: CT: computed tomography; MRI: magnetic resonance imaging </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"Randomisation algorithm developed by chief study statistician"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"Local site personnel call the Automated Phone Registration System for AAASPS operated by the Moffitt Cancer Research Institute of the University of South Florida ... for allocation" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"all study personnel were masked (blinded) from treatment assignment with the exception of 1 study statistician who developed the randomization algorithm" </p> <p>"placebo tablets had identical physical properties"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>276 participants withdrew in the Ticlopidine group and 246 in the Aspirin group. Analysis was done on intention‐to‐treat basis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes reported as stated in the published protocol</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"Roche Laboratories and Bayer had no role beyond supplying study medications and placebos."</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">CAPRIE 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL, RANDOMISATION RATIO: 1:1, EQUIVALENCE DESIGN</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INCLUSION CRITERIA</b>: </p> <p>Ischaemic stroke: (including retinal and lacunar infarction) ≥ 1 week and ≤ 6 months and neurological signs persisting ≥ 1 week from stroke onset and CT or MRI ruling out haemorrhage or non‐relevant disease </p> <p>MI: Onset ≤ 35 days before randomisation and two of:</p> <p>Characteristic ischaemic pain for ≥ 20 min</p> <p>Elevation of CK, CK‐MB, LDH, or AST to 2 times upper limit of laboratory normal with no other explanation </p> <p>Development of new ≥ 40 Q waves in at least two adjacent ECG leads <i>or</i> new dominant R wave in V1 (R ≥ 1 mm &gt; S in V1) </p> <p>Atherosclerotic peripheral arterial disease: Intermittent claudication (WHO: leg pain on walking, disappearing in &lt; 10 min on standing) of presumed atherosclerotic origin; and ankle/arm systolic BP ratio ≤ 0·85 in either leg at rest (two assessments on separate days); or history of intermittent claudication with previous leg amputation, reconstructive surgery, or angioplasty with no persisting complications from intervention </p> <p><b>EXCLUSION CRITERIA</b>: </p> <p>Age &lt; 21 years</p> <p>Severe cerebral deficit likely to lead to patient being bedridden or demented</p> <p>Carotid endarterectomy after qualifying stroke</p> <p>Qualifying stroke induced by carotid endarterectomy or angiography</p> <p>Patient unlikely to be discharged alive after qualifying event</p> <p>Severe comorbidity likely to limit patient's life expectancy to less than 3 years</p> <p>Uncontrolled hypertension</p> <p>Scheduled for major surgery</p> <p>Contraindications to study drugs</p> <p>Severe renal or hepatic insufficiency</p> <p>Haemostatic disorder or systemic bleeding</p> <p>History of haemostatic disorder or systemic bleeding</p> <p>History of thrombocytopenia or neutropenia</p> <p>History of drug‐induced haematologic or hepatic abnormalities</p> <p>Known to have abnormal WBC, differential, or platelet count</p> <p>Anticipated requirement for long‐term anticoagulants, non‐study antiplatelet drugs or NSAIDs affecting platelet function </p> <p>History of aspirin sensitivity</p> <p>Women of childbearing age not using reliable contraception</p> <p>Currently receiving investigation drug</p> <p>Previously entered in other clopidogrel studies</p> <p>Geographic or other factors making study participation impractical</p> <p><b>CO‐MEDICATIONS</b>: </p> <p>Antiplatelet or anticoagulation drugs were discontinued before randomisation. Patients with anticipated need for long term anticoagulation or NSAIDs were excluded. Concomitant medications were recorded. </p> <p><b>PARTICIPANTS</b>: </p> <p>Total participants: 19,185 (Aspirin: 9546, Clopidogrel: 9553) [86 did not receive medication, Aspirin 40, Clopidogrel 46] </p> <p>Diabetes participants: 3866 (Aspirin: 20% of total group, Clopidogrel: 20% of total group) </p> <p>Total participants withdrawn or prematurely discontinuing study medication: 4059 (Aspirin: 21.1%, Clopidogrel: 21.3%) </p> <p>Total participants lost to follow‐up: 42 (Aspirin: 20, Clopidogrel: 22)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INTERVENTION</b>: Clopidogrel 75 mg daily and placebo </p> <p><b>CONTROL</b>: Aspirin 325 mg daily and placebo </p> <p><b>NUMBER OF STUDY CENTRES</b>: 384 centres </p> <p><b>COUNTRY/ LOCATION</b>: 16 countries </p> <p><b>SETTING</b>: Hospital and community </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>OUTCOMES</b> (<i>as stated in the publication):</i><b>&nbsp;</b> </p> <p>Non‐fatal Ischaemic Stroke: acute neurological event with focal signs for ≥ 24 hrs; if new location without evidence of intracranial haemorrhage; if worsening of previous event, must have lasted &gt; 1 week, or more than 24 hrs if accompanied by appropriate CT or MRI findings </p> <p>Non‐fatal MI: same as inclusion criteria</p> <p>Non‐fatal primary intracranial haemorrhage: Intracerebral haemorrhage (including intracranial and subarachnoid), and subdural haematoma documented by appropriate neuroimaging investigations. </p> <p>Non‐fatal leg amputation: Only if above the ankle and not done for trauma or cancer.</p> <p>Fatal events: Ischaemic stroke (within 28 days of onset of symptoms/signs), MI (within 28 days of onset of symptoms signs), haemorrhage, other vascular causes (deaths that were not clearly non‐vascular and did not meet other criteria) or non‐vascular causes </p> <p>All cause mortality patients with diabetes: unknown</p> <p>All cause mortality all patients: Aspirin: 571, Clopidogrel: 560</p> <p>Vascular mortality patients with diabetes: unknown</p> <p>Vascular mortality all patients: Aspirin: 378, Clopidogrel: 350</p> <p>Myocardial infarction patients with diabetes (fatal): unknown</p> <p>Myocardial infarction patients with diabetes (non‐fatal): unknown</p> <p>Myocardial infarction all patients (fatal): Aspirin: 75, Clopidogrel: 53</p> <p>Myocardial infarction all patients (non‐fatal): Aspirin: 301, Clopidogrel: 255</p> <p>Stroke patients with diabetes (fatal): unknown</p> <p>Stroke patients with diabetes (non‐fatal): unknown</p> <p>Stroke all patients (fatal): Aspirin: 42, Clopidogrel: 37</p> <p>Stroke all patients (non‐fatal): Aspirin: 504, Clopidogrel: 472</p> <p>Serious adverse event patients with diabetes: unknown</p> <p>Serious adverse event all patients: Aspirin: 409, Clopidogrel: 360</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RUN‐IN PERIOD</b>: No </p> <p><b>STUDY TERMINATED BEFORE REGULAR END</b>: No (recruitment completed early but follow‐up remained at one year post recruitment completion) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b> </p> <p><b>PUBLICATION STATUS: PEER REVIEW JOURNAL</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>“to assess the potential benefit of clopidogrel, compared with aspirin, in reducing the risk of ischaemic stroke, myocardial infarction, or vascular death in patients with recent ischaemic stroke, recent myocardial infarction or peripheral arterial disease” </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>This study was funded by Sanofi and Bristol‐Myers Squibb</p> <p><b>Abbreviations:</b> AST aspartate aminotransferase; BP: blood pressure; CK: creatine kinase; CK‐MB: creatine kinase myocardial band; CT: computed tomography; ECG: electrocardiogram; LDH: lactate dehydrogenase; MI: myocardial infarction; MRI: magnetic resonance imaging; WBC: white blood cells; WHO: World Health Organisation </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>“The Independent Statistical Centre provided computer‐generated .... with random allocation”</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>“The Independent Statistical Centre provided computer‐generated .... with random allocation”</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"These [Medication] supplies were in the form of blister packs containing either 75 mg tablets of clopidogrel plus aspirin placebo tablets or 325 mg aspirin tablets plus clopidogrel placebo tablets, such blister packs being indistinguishable from one another " </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>“19,185 patients ... were randomised”; “46 patients in clopidogrel group and 40 in aspirin group never took any study drug”; “42 patients lost to follow‐up ... included in the analysis” </p> <p>“4059 patients discontinued study drug early...., 21.3% in clopidogrel and 21.1% in the aspirin group.&nbsp; Reasons for stopping study drug early were similar in the two groups”. </p> <p>Comment: equal loss in both groups, included in analysis.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Registration of trial or prior protocol publication unavailable. Outcomes stated in publication document reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"This study was funded by Sanofi and Bristol‐Myers Squibb"</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">CATS 1988 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL, RANDOMISATION RATIO: 1:1, EQUIVALENCE DESIGN</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INCLUSION CRITERIA</b>: </p> <p>Thromboemoblic stroke 1 week to 4 months prior to entry into study</p> <p>Diagnosis based on clinical assessment and history</p> <p>Neurological deficit had to be persistent at time of entry into study</p> <p>CT scan excluded haemorrhagic stroke or other intracerebral pathology</p> <p><b>EXCLUSION CRITERIA</b>: </p> <p>Cardioembolic strokes (defined as two of AF, sick sinus syndrome, seizure at onset, involvement in more than one vascular territory)&nbsp; </p> <p>Bedridden or dementia</p> <p>Life‐limiting illness</p> <p>Contraindications to ticlopidine (hepatic or renal insufficiency, haemostatic disorder, thrombocytopenia, history of drug‐induced haematologic abnormalities) </p> <p>Significant laboratory test abnormalities</p> <p>Carotid endarterectomy prior to randomisation</p> <p>Stroke due to carotid endarterectomy</p> <p>Long term anticoagulation or antiplatelet therapy required</p> <p>History of drug or alcohol abuse</p> <p>Inclusion in another trial</p> <p><b>PARTICIPANTS</b>: </p> <p>Total participants: 1053 (Ticlodipine: 525, Placebo: 528)</p> <p>Diabetes participants: 335 (Ticlodipine: 172, Placebo: 163)</p> <p>Total participants withdrawn or prematurely discontinuing study medication: 402 (Ticlodipine: 238, Placebo: 164) </p> <p>Total participants lost to follow‐up: 4 (Ticlodipine: 3, Placebo: 1)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INTERVENTION</b>: Ticlopidine 250 mg twice daily </p> <p><b>CONTROL</b>: Placebo </p> <p><b>NUMBER OF STUDY CENTRES</b>: 25 </p> <p><b>COUNTRY/ LOCATION</b>: USA and Canada </p> <p><b>SETTING</b>: Hospital inpatient </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>OUTCOMES</b> (<i>as reported in published protocol)</i>: </p> <p>Non‐fatal stroke: </p> <p>Diagnosis based on clinical assessment and history</p> <p>Duration of &gt; 24 hours if in new location or &gt; 1 week if worsening of previous deficit unless accompanied by new CT finding </p> <p>CT scan excluded haemorrhagic stroke or other intracerebral pathology</p> <p>Non‐fatal myocardial infarction: </p> <p>At least two of:</p> <p>a) typical symptoms of pain</p> <p>b) compatible ECG changes or positive pyrophosphate radionuclide scan</p> <p>c) appropriate serum enzyme changes (peak value &gt; twice upper limit of normal)</p> <p>Vascular death: </p> <p>New cerebral infarction</p> <p>Myocardial infarction</p> <p>Sudden death</p> <p>Congestive heart failure</p> <p>All cause mortality patients with diabetes: 30 ticlopidine, 23 placebo</p> <p>All cause mortality all patients: 66 ticlopidine, 65 placebo</p> <p>Vascular mortality patients with diabetes with diabetes: 18 ticlopidine, 18 placebo</p> <p>Vascular mortality all patients: 35 ticlopidine, 43 placebo</p> <p>Myocardial infarction patients with diabetes (fatal): 13 ticlopidine, 10 placebo</p> <p>Myocardial infarction patients with diabetes (non‐fatal): 3 ticlopidine, 9 placebo</p> <p>Myocardial infarction all patients (fatal): 21 ticlopidine, 22 placebo</p> <p>Myocardial infarction all patients (non‐fatal): 11 ticlopidine, 15 placebo</p> <p>Stroke patients with diabetes (fatal): 6 ticlopidine, 9 placebo</p> <p>Stroke patients with diabetes (non‐fatal): 28 ticlopidine, 32 placebo</p> <p>Stroke all patients (fatal): 14 ticlopidine, 17 placebo</p> <p>Stroke all patients (non‐fatal): 67 ticlopidine, 86 placebo</p> <p>Serious adverse event patients with diabetes: unknown</p> <p>Serious adverse event all patients: 43 ticlopidine, 15 placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RUN‐IN PERIOD</b>: No </p> <p><b>STUDY TERMINATED BEFORE REGULAR END</b>: No </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b> </p> <p><b>PUBLICATION STATUS: PEER REVIEW JOURNAL</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>“to assess the effect of ticlopidine (250 mg twice daily) in reducing the rate of subsequent occurrence of stroke, myocardial infarction, or vascular death in patients who have had a recent thromboembolic stroke" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>This study was funded by Syntax Research (USA) Inc and Sanofi, France</p> <p><b>Abbreviations:</b> AF: atrial fibrillation; CT: computed tomography; ECG: electrocardiogram </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Prescribed randomisation arrangement generated separately for each clinical centre, 528 patients randomised to placebo, 525 to ticlopidine </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Only the safety committee knew the randomisation code for a particular centre</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ticlopidine was supplied.... in plastic containers .... placebo tablets were identical in packaging and appearance </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4 patients lost to follow‐up, 3 in ticlopidine group, 1 in placebo group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Registration of trial or prior protocol publication unavailable. Outcomes stated in publication document reported </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Funded by pharmaceutical company</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">CHARISMA 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL, RANDOMISATION RATIO: 1:1, EQUIVALENCE DESIGN</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INCLUSION CRITERIA</b>: </p> <p>High risk primary prevention: 2 major risk factors or 3 minor risk factors or 1 major and 2 minor risk factors. </p> <p><i>Major risk factors</i>: </p> <p>Diabetes mellitus (on drug therapy)</p> <p>Diabetic neuropathy</p> <p>ABI &lt; 0.9</p> <p>Asymptomatic carotid stenosis ≥ 70%</p> <p>Carotid plaque evidence by intima‐media thickness</p> <p><i>Minor risk factors</i>: </p> <p>Systolic BP ≥ 150 mm Hg despite therapy for 3 months</p> <p>Primary hypercholesterolaemia</p> <p>Current smoker &gt; 15 cigarettes per day</p> <p>Male ≥ 65 years, female ≥ 70 years</p> <p>Coronary artery disease: 1 of:</p> <p>Stable angina with document multivessel coronary disease</p> <p>History of multivessel CABG</p> <p>History of multivessel PCI</p> <p>Previous MI</p> <p>Cerebrovascular disease: previous ischaemic stroke or TIA</p> <p>Peripheral arterial disease: intermittent claudication with ABI ≤ 0.85 or intermittent claudication with previous intervention </p> <p><b>EXCLUSION CRITERIA</b>: </p> <p>Chronic oral antithrombotic medications (warfarin, high dose aspirin, NSAIDs)</p> <p>Requiring prolonged clopidogrel therapy</p> <p><b>CO‐MEDICATIONS</b>: </p> <p>Concurrent oral antithrombotic therapy not permitted. Other standard therapy at the discretion of clinicians. </p> <p><b>PARTICIPANTS</b>: </p> <p>Total participants: 15,603 (Clopidogrel: 7802, Placebo: 7801)</p> <p>Diabetes participants: 6556 (Clopidogrel: 3304, Placebo: 3252)</p> <p>Total participants withdrawn or prematurely discontinuing study medication: Clopidogrel: 20.4%, Placebo: 18.2% </p> <p>Total participants lost to follow‐up: unknown</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INTERVENTION</b>: Clopidogrel 75 mg daily and aspirin 75 mg to 162 mg daily </p> <p><b>CONTROL</b>: Placebo and aspirin 75 mg to 162 mg daily </p> <p><b>NUMBER OF STUDY CENTRES</b>: 768 </p> <p><b>COUNTRY/ LOCATION</b>: 32 countries </p> <p><b>SETTING</b>: Hospital </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>OUTCOMES</b> (<i>as stated in the published protocol)</i>: </p> <p>Primary outcome: first occurrence of cardiovascular death, MI (according to American College of Cardiology definition) or stroke (acute onset of focal neurological symptoms or signs lasting more than 24 hours, with CT or MRI to exclude other causes). </p> <p>All cause mortality patients with diabetes: unknown</p> <p>All cause mortality all patients: Clopidogrel: 371, Placebo: 374</p> <p>Vascular mortality patients with diabetes: unknown</p> <p>Vascular mortality all patients: Clopidogrel: 238, Placebo: 229</p> <p>Myocardial infarction patients with diabetes (fatal): unknown</p> <p>Myocardial infarction patients with diabetes (non‐fatal): unknown</p> <p>Myocardial infarction all patients (fatal): unknown</p> <p>Myocardial infarction all patients (non‐fatal): Clopidogrel: 146, Placebo: 155</p> <p>Stroke patients with diabetes (fatal): unknown</p> <p>Stroke patients with diabetes (non‐fatal): unknown</p> <p>Stroke all patients (fatal): unknown</p> <p>Stroke all patients (non‐fatal): Clopidogrel: 150, Placebo: 189</p> <p>Serious adverse event patients with diabetes: unknown</p> <p>Serious adverse event all patients (only bleeding recorded): Clopidogrel: 130, Placebo: 104 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RUN‐IN PERIOD</b>: No </p> <p><b>STUDY TERMINATED BEFORE REGULAR END</b>: No </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL &amp; NON‐COMMERCIAL FUNDING</b> </p> <p><b>PUBLICATION STATUS: PEER REVIEW JOURNAL</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>To test if "clopidogrel in combination with aspirin would be an improvement over aspirin alone across the spectrum of high risk patients with atherothrombosis" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Sponsored and funded by Sanofi‐Aventis and Bristol‐Myers Squibb and the National Institutes of Health </p> <p><b>Abbreviations:</b> ABI: ankle brachial index; CABG: coronary artery bypass grafting; CT: computed tomography; MI: myocardial infarction; MRI: magnetic resonance imaging; NSAIDs: non‐steriodal anti‐inflammatory drugs; PCI: percutaneous coronary intervention; TIA: transient ischaemic attack </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"pre‐established randomisation scheme, stratified according to site"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"Study drug assignment was performed centrally by an interactive voice‐response system"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"Matching placebo drug"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Withdrawal rate 20% for clopidogrel group, 18.2% for placebo group. Number of patients lost to follow‐up unknown. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes reported as stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Pharmaceutical funding from Sanofi‐Aventis and Bristol‐Myers Squibb</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">CURE 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL, RANDOMISATION RATIO: 1:1, EQUIVALENCE DESIGN</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INCLUSION CRITERIA</b>: </p> <p>Admitted to hospital with: </p> <p>Symptoms suggestive of ACS without ST segment elevation &gt; 1 mm</p> <p>Within 24 hours of onset of chest pain/symptoms</p> <p>Either ECG changes compatible with new ischaemia <i>or</i> elevated cardiac enzymes or troponin I or T at least twice upper limit of normal </p> <p><b>EXCLUSION CRITERIA</b>: </p> <p>Contraindications to antiplatelet/antithrombotic therapy</p> <p>High risk of bleeding</p> <p>Class IV heart failure</p> <p>Ongoing long term need for anticoagulants</p> <p>PTCA/stent or CABG within 3 months prior to randomisation</p> <p><b>CO‐MEDICATIONS</b>: </p> <p>Aspirin (75 mg to 325 mg) started at randomisation or continued if already taking</p> <p><b>PARTICIPANTS</b>: </p> <p>Total participants: 12,562 (Clopidogrel: 6259, Placebo: 6303)</p> <p>Diabetes participants: 2840 (Clopidogrel: 1405, Placebo: 1435)</p> <p>Total participants withdrawn or prematurely discontinuing study medication: Clopidogrel: 21.1%, Placebo: 18.8% </p> <p>Total participants lost to follow‐up: 13 (Clopidogrel: 6, Placebo: 7)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INTERVENTION</b>: 300 mg loading dose of clopidogrel then 75 mg per day and aspirin 75 mg to 325 mg daily </p> <p><b>CONTROL</b>: Placebo and aspirin 75 mg to 325 mg daily </p> <p><b>NUMBER OF STUDY CENTRES</b>: 482 </p> <p><b>COUNTRY/ LOCATION</b>: 28 countries </p> <p><b>SETTING</b>: Hospital </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>OUTCOMES</b> (<i>as stated in the published protocol)</i>: </p> <p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The composite of cardiovascular death, non‐fatal myocardial infarction or stroke </p> <p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The composite of cardiovascular death, non‐fatal myocardial infarction, stroke or refractory ischaemia </p> <p>Death from cardiovascular cause: death for which there was no clearly documented non‐vascular cause </p> <p>Myocardial infarction: presence of at least two of: ischaemic chest pain, elevation of cardiac markers or enzymes to at least twice upper limit of normal within 48 hours after percutaneous coronary intervention (or to a level 20% higher than the previous value if the level had already been elevated because of an early myocardial infarction), ECG changes compatible with infarction </p> <p>Stroke: result of intracranial haemorrhage, ischaemia or uncertain cause</p> <p>Refractory ischaemia in hospital: recurrent chest pain lasting more than five minutes with new ischaemic ECG changes while the patient was receiving optimal medical therapy (two anti‐anginal agents, including V nitrate unless contraindicated) leading to additional intervention by midnight of the next calendar day. </p> <p>Refractory ischaemia on discharge: rehospitalisation lasting at least 24 hours for unstable angina with ischaemic ECG changes </p> <p>Severe ischaemia: Ischaemia similar to refractory ischaemia for which no urgent intervention was performed </p> <p>All cause mortality patients with diabetes: unknown</p> <p>All cause mortality all patients: Clopidogrel: 359, Placebo: 390</p> <p>Vascular mortality patients with diabetes: unknown</p> <p>Vascular mortality all patients: Clopidogrel: 318, Placebo: 345</p> <p>Myocardial infarction patients with diabetes (fatal): unknown</p> <p>Myocardial infarction patients with diabetes (non‐fatal): unknown</p> <p>Myocardial infarction all patients (fatal and non‐fatal): Clopidogrel: 324, Placebo 419 </p> <p>Stroke patients with diabetes (fatal): unknown</p> <p>Stroke patients with diabetes (non‐fatal): unknown</p> <p>Stroke all patients (fatal and non‐fatal): Clopidogrel: 75, Placebo: 87</p> <p>Serious adverse event patients with diabetes: unknown</p> <p>Serious adverse event all patients (only bleeding recorded): Clopidogrel: 231, Placebo: 169 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RUN‐IN PERIOD</b>: No </p> <p><b>STUDY TERMINATED BEFORE REGULAR END</b>: No – study initially designed for 9000 patients, however, increased to 12,500 due to lower event rates than expected </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b> </p> <p><b>PUBLICATION STATUS: PEER REVIEW JOURNAL</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>“To compare the efficacy and safety of the early and long‐term use of clopidogrel plus aspirin with those of aspirin alone in patients with acute coronary syndromes and no ST‐segment elevation” </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Supported by Sanofi‐Synthelabo and Bristol‐Myers Squibb</p> <p><b>Abbreviations:</b> ACS: acute coronary syndrome; ECG: electrocardiogram; PTCA: percutaneous transluminal coronary angioplasty; CABG: coronary artery bypass grafting </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"Randomised to either clopidogrel or placebo by telephone call to central computerised randomisation service" </p> <p>“Permuted block randomisation .... is used”</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>“Telephone call to central computerised randomisation service”</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>“Blinded study drug... matching placebo”</p> <p>“A central committee of clinicians who are blinded to treatment allocation will adjudicate ... outcomes” </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>“Vital status was ascertained for 12,549 of the 12,562 patients who underwent randomization (99.9 percent), with 6 patients in the clopidogrel group and 7 in the placebo group lost to follow‐up” </p> <p>“46.2% of patients in clopidogrel group discontinued study medication ... as compared with 45.4% in the placebo group” </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome data reported as stated in published protocol</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Funded by pharmaceutical company</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Park 2010 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL, RANDOMISATION RATIO: 1:1, EQUIVALENCE DESIGN</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INCLUSION CRITERIA</b>: </p> <p>Undergone implantation of drug eluting stents at least 12 months before enrolment</p> <p>Receiving dual antiplatelet therapy at time of enrolment</p> <p><b>EXCLUSION CRITERIA</b>: </p> <p>Major adverse cardiovascular event (myocardial infarction, stroke, repeat revascularisation) since implantation </p> <p>Major bleeding since implantation</p> <p>Contraindications to the use of antiplatelet drugs</p> <p>Requirement of long term clopidogrel</p> <p>Non‐cardiac coexisting condition with anticipated life expectancy of less than one year </p> <p>Participitation in another trial</p> <p><b>CO‐MEDICATIONS</b>: </p> <p>Usual care as per treating physician</p> <p><b>PARTICIPANTS</b>: </p> <p>Total participants: 2701 (Clopidogrel and aspirin: 1357, Aspirin only: 1344)</p> <p>Diabetes participants: 704 (Clopidogrel and aspirin: 340, Aspirin: 364)</p> <p>Total participants withdrawn or prematurely discontinuing study medication: 2061 (Clopidogrel and aspirin: 1030, Aspirin: 1031) </p> <p>Total participants lost to follow‐up: unknown</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INTERVENTION</b>: Clopidogrel 75 mg daily and aspirin 100 mg to 200 mg daily </p> <p><b>CONTROL</b>: Aspirin 100 mg to 200 mg per day </p> <p><b>NUMBER OF STUDY CENTRES</b>: 22 </p> <p><b>COUNTRY/ LOCATION</b>: South Korea </p> <p><b>SETTING</b>: Inpatient and community </p> <p><b>TREATMENT BEFORE STUDY</b>: Dual antiplatelet therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>OUTCOMES</b> (<i>as stated in registered trial documents):</i> </p> <p>Myocardial infarction <br> Death from cardiac causes </p> <p>Death from any cause</p> <p>Composite of myocardial infarction, stoke, death from cardiac causes</p> <p>Major bleeding</p> <p>All cause mortality patients with diabetes: unknown</p> <p>All cause mortality all patients: Aspirin and clopidogrel: 20, Aspirin only 13</p> <p>Vascular mortality patients with diabetes: unknown</p> <p>Vascular mortality all patients: unknown</p> <p>Myocardial infarction patients with diabetes (fatal and non‐fatal): unknown</p> <p>Myocardial infarction all patients (fatal and non‐fatal): Aspirin and clopidogrel: 10, Aspirin only: 7 [specific numbers for fatal and non‐fatal unknown] </p> <p>Stroke patients with diabetes (fatal and non‐fatal): unknown</p> <p>Stroke all patients (fatal and non‐fatal): Aspirin and clopidogrel: 9, Aspirin only: 4 [specific numbers for fatal and non‐fatal unknown] </p> <p>Major bleeding patients with diabetes: unknown</p> <p>Major bleeding all patients: Aspirin and clopidogrel: 3, Aspirin only: 1</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RUN‐IN PERIOD</b>: No </p> <p><b>STUDY TERMINATED BEFORE REGULAR END</b>: No </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b>: No </p> <p><b>NON</b>‐<b>COMMERCIAL FUNDING</b>: Unknown </p> <p><b>PUBLICATION STATUS: PEER REVIEW JOURNAL</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>"evaluated the effect of the use of dual antiplatelet therapy for more than 12 months on long‐term clinical outcomes in patients who had undergone initial PCI with the placement of a drug‐eluting stent" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>"There was no industry involvement in the design, conduct, financial support, or analysis"</p> <p><b>Abbrevations:</b> PCI: percutaneous coronary intervention </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"assignments were made according to a pre‐established, computer‐generated randomization scheme, with stratification on the basis of site and type of ... drug eluting stent" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"the trial was open label study..... subjects and the investigators were aware of the treatment assignments" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants and investigators were not blinded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>More than half of the patients discontinued study medication by the end of the study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes reported as stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"no industry involvement in the design, conduct, financial support, or analysis"</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">PRoFESS 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL, RANDOMISATION RATIO: 1:1, EQUIVALENCE DESIGN</b> </p> <p><b>FACTORIAL RCT: 2 x 2 factorial design comparing aspirin and dipyridamole with clopidogrel and telmisartan with placebo</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INCLUSION CRITERIA</b>: </p> <p>1. Patients ≥ 55 years AND ischaemic stroke within 90 days before randomisation.</p> <p>After enrolment of 6000 patients the protocol was amended to broaden the inclusion criteria as follows: </p> <p>2. Patients 50to 54 years AND ischaemic stroke within 120 days AND two additional risk factors (diabetes mellitus, hypertension, smoker at time of qualifying stroke, obesity (body mass index &gt; 30), previous vascular disease (stroke, MI or peripheral arterial disease), end‐organ damage (retinopathy, left ventricular hypertrophy or microalbuminuria) or hyperlipidaemia. </p> <p>3. Patients ≥ 55 years AND ischaemic stroke within 120 days AND two additional risk factors </p> <p><b>EXCLUSION CRITERIA</b>: </p> <p>1. Patients unable to give informed consent <br> 2. Patients presenting with a primary haemorrhagic stroke (intracerebral haemorrhage or subarachnoid haemorrhage) <br> 3. Patients who are unable to take by mouth all required study medication <br> 4. Known brain tumour <br> 5. Pre‐stroke history of dementia requiring institutional care <br> 6. A modified Rankin scale score &gt; 4 at baseline <br> 7. The patient is unlikely to be released from hospital following the qualifying stroke, or the presence of a severe disability after the qualifying stroke likely to lead to the patient being bedridden or demented, or a non‐vascular disease or condition which makes it unlikely that the patient will survive to the end of the trial <br> 8. Patients whose qualifying stroke had been induced by a surgical or cardiovascular procedure such as carotid endarterectomy, angiogram or cardiac surgery <br> 9. Patients with known hypersensitivity to dipyridamole, clopidogrel, aspirin or telmisartan </p> <p>10. Uncontrolled hypertension which equals or exceeds either a sitting systolic BP greater than 180 mm Hg, or a sitting diastolic BP greater than 110 mm Hg (all hypertensive patients are treated appropriately, and ‘goal’ BPs are much lower than 180/110) <br> 11. Seated systolic BP ≤ 120 mm Hg for patients who are still hospitalised following the qualifying stroke <br> 12. Patients currently being treated with an angiotensin II receptor blocker who are unable or unwilling to discontinue treatment with this type of drug <br> 13. Patients with required or planned continued treatment with antithrombotics or anticoagulants including heparin or warfarin, or non‐study platelet inhibitors <br> 14. Known severe renal insufficiency defined as renal artery stenosis or creatinine clearance &lt; 0.6 ml/s or serum creatinine &gt; 265 μmol/L (&gt; 3.0 mg/dL) <br> 15. Known severe hepatic dysfunction as defined by the following laboratory parameters: SGPT (ALT) or SGOT (AST) &gt; 4 times upper limit of normal, or total bilirubin &gt; 20 μmol/L <br> 16. Hyperkalaemia, defined as potassium &gt; 5.5 mmol/L <br> 17. Uncorrected volume depletion or sodium depletion <br> 18. Known current active peptic ulcer disease <br> 19. Patients with the syndrome of asthma, rhinitis and nasal polyps (all three present) <br> 20. Known severe coronary artery disease including unstable angina pectoris or an MI within the previous 3 months </p> <p>21. Patients considered unreliable by the investigator concerning the requirements for follow‐up during the study and/or compliance with study drug administration </p> <p>22. Known presence of or history of a haemostatic disorder or systemic bleeding <br> 23. History of thrombocytopenia (i.e. less than 100 × 109/L for platelets) or neutropenia (1.2 × 109/L for neutrophils) <br> 24. Women who are breast‐feeding, pregnant or of childbearing potential who do not use a medically acceptable form of contraception <br> 25. Patients who have been exposed to an investigational drug or device within the last 30 days, or are currently participating in such a trial <br> 26. Patients scheduled for major surgery, carotid endarterectomy or carotid angioplasty should not enter the study; such patients may enter the trial 4 weeks after such procedures, if they still meet all other entry criteria </p> <p><b>PARTICIPANTS</b>: </p> <p>Total participants: 20,332 (Clopidogrel: 10,151, Aspirin/dipyridamole: 10,181)</p> <p>Diabetes participants: 5743 (Clopidogrel: 2840, Aspirin/dipyridamole: 2903)</p> <p>Total participants withdrawn or prematurely discontinuing study medication: Clopidogrel: 2290, Aspirin/dipyridamole: 2961) </p> <p>Total participants lost to follow‐up: 250 (Clopidogrel: 125, Aspirin/dipyridamole: 125) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INTERVENTION</b>: Clopidogrel 75 mg daily and placebo </p> <p><b>CONTROL</b>: Aspirin/dipyridamole 25 mg/200 mg twice daily and placebo </p> <p><i>For the first 8 months, 2027 patients in the clopidogrel group were receiving aspirin and clopidogrel however the MATCH trial demonstrated increased bleeding with aspirin and clopidogrel so the protocol was changed to clopidogrel only.</i> </p> <p><b>NUMBER OF STUDY CENTRES</b>: 695 </p> <p><b>COUNTRY/ LOCATION</b>: 35 countries </p> <p><b>SETTING</b>: Hospital and community </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>OUTCOMES</b> (<i>as stated in the published protocol)</i>: </p> <p>Primary outcome event: <br> Stroke (non‐fatal or fatal) either ischaemic <i>or</i> haemorrhagic <i>or</i> of uncertain cause </p> <p>Secondary outcome events: <br> Vascular events either stroke <i>or</i> MI <i>or</i> vascular death </p> <p>All cause mortality patients with diabetes: unknown</p> <p>All cause mortality all patients: Clopidogrel: 756, Aspirin/dipyridamole: 739</p> <p>Vascular mortality patients with diabetes: unknown</p> <p>Vascular mortality all patients: unknown</p> <p>Myocardial infarction patients with diabetes (fatal and non‐fatal): unknown</p> <p>Myocardial infarction all patients (fatal and non‐fatal): Clopidogrel: 197, Aspirin/dipyridamole: 178 [specific numbers for fatal and non‐fatal unknown] </p> <p>Stroke patients with diabetes (fatal and non‐fatal): Clopidogrel: 334, Aspirin/dipyridamole: 312 [specific numbers for fatal and non‐fatal unknown] </p> <p>Stroke all patients (fatal and non‐fatal): Clopidogrel: 862, Aspirin/dipyridamole: 879 [specific numbers for fatal and non‐fatal unknown] </p> <p>Serious adverse event patients with diabetes: unknown</p> <p>Serious adverse event all patients (only bleeding recorded): Clopidogrel: 365, Aspirin/dipyridamole: 419 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RUN‐IN PERIOD</b>: No </p> <p><b>STUDY TERMINATED BEFORE REGULAR END</b>: No </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b> </p> <p><b>PUBLICATION STATUS: PEER REVIEW JOURNAL</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>"to compare the relative efficacy and safety of aspirin plus extended‐release dipyridamole with that of clopidogrel among patients who had a recent ischemic stroke" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Supported by Boehringer Ingelheim (which manufactures Aggrenox [a combination of extended‐release dipyridamole and aspirin] and Micardis [telmisartan]) </p> <p><b>Abbreviations:</b> BP: blood pressure; MI: myocardial infarction; SGOT (AST): Serum glutamic oxaloacetic transaminase / aspartate transaminase;.SGPT (ALT): Serum glutamic pyruvate transaminase / alanine transaminase </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"The randomization to telmisartanwas stratified based on whether or not individuals were receiving ACE inhibitors, although the analysis will be based on both strata combined. Patients were randomized using a central telephone randomization system." (from protocol of PRoFESS) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"Patients were randomized using a central telephone randomization system"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"the medication was ‘double dummy’ ... so that all patients received identically appearing medication kits" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>175 patients lost in both groups</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes reported as stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"the ASA active and placebo component of the clopidogrel arm was discontinued following the presentation of the MATCH results and removed from subsequent treatment kits" </p> <p>Funded by Boehringer Ingelheim</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">TASS 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RANDOMISED CONTROLLED CLINICAL TRIAL, RANDOMISATION RATIO: 1:1, EQUIVALENCE DESIGN</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INCLUSION CRITERIA</b><i>:</i> </p> <p><i>One of the following within the past 3 months:</i> </p> <p>Transient Ischaemic attack: focal ischaemic cerebrovascular event lasting &lt; 24 hours followed by complete recovery </p> <p>Amaurosis fugax: unilateral ischaemic retinal episode lasting &lt; 24 hours</p> <p>Reversible ischaemic neurologic deficit: focal ischaemic cerebrovascular event lasting &gt; 24 hours and &lt; 3 weeks followed by complete recovery </p> <p>Minor stroke: focal ischaemic cerebrovascular event results in minimal permanent neurologic deficit and at least 80% recovery of function within three weeks </p> <p><b>EXCLUSION CRITERIA</b>: </p> <p>Carotid artery surgery within last three months</p> <p>Moderate to major stroke within last three months</p> <p>Women with child bearing potential</p> <p>Cardiogenic embolism</p> <p>Haematological disorders</p> <p>History of peptic ulcer disease or gastrointestinal bleeding</p> <p>Life‐threatening diseases such as cancer</p> <p>Hypersensitivity or intolerance to aspirin</p> <p>Need for continued use of aspirin or anticoagulants</p> <p>CONCURRENT MEDICATIONS: Anticoagulants and antiplatelets prohibited.</p> <p><b>PARTICIPANTS</b>: </p> <p>Total participants: 3069 (Ticlodipine: 1529, Aspirin: 1540) [12 participants later judged ineligible] </p> <p>Diabetes participants: 597 (Ticlodipine: 291, Aspirin: 306)</p> <p>Total participants withdrawn or prematurely discontinuing study medication: 1216 (Ticlopidine: 655, Aspirin: 561) </p> <p>Total participants lost to follow‐up: 84 (Ticlodipine: 46, Aspirin: 38)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>INTERVENTION</b>: Ticlopidine 250 mg twice daily </p> <p><b>CONTROL</b>: Aspirin 650 mg twice daily </p> <p><b>NUMBER OF STUDY CENTRES</b>: 56 </p> <p><b>COUNTRY/ LOCATION</b>: United States and Canada </p> <p><b>SETTING</b>: Hospital and community </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>OUTCOMES</b><i>(as stated in the published report):</i> </p> <p>Stroke: Demonstration of brain infarction at autopsy or rapid onset of focal cerebral dysfunction &gt; 24 hours associated with typical findings on neurologic examination, laboratory studies and radiologic tests </p> <p>Death from all causes</p> <p>All cause mortality patients with diabetes: unknown</p> <p>All cause mortality all patients: Ticlopidine: 175, Aspirin: 196</p> <p>Vascular mortality patients with diabetes: unknown</p> <p>Vascular mortality all patients: Ticlopidine: 120, Aspirin: 116</p> <p>Myocardial infarction patients with diabetes (fatal): unknown</p> <p>Myocardial infarction patients with diabetes (non‐fatal): unknown</p> <p>Myocardial infarction all patients (fatal): Ticlopidine: 21, Aspirin: 14</p> <p>Myocardial infarction all patients (non‐fatal): unknown</p> <p>Stroke patients with diabetes (fatal and non‐fatal): Ticlopidine: 25, Aspirin: 44 [specific numbers for fatal and non‐fatal unknown] </p> <p>Stroke all patients (fatal): Ticlopidine: 16, Aspirin: 23</p> <p>Stroke all patients (non‐fatal): Ticlopidine: 156, Aspirin:189</p> <p>Serious adverse event patients with diabetes: unknown</p> <p>Serious adverse event (bleeding only) all patients: Ticlopidine: 137, Aspirin: 152</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>RUN‐IN PERIOD</b>: No </p> <p><b>STUDY TERMINATED BEFORE REGULAR END</b>: No </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>LANGUAGE OF PUBLICATION</b>: English </p> <p><b>COMMERCIAL FUNDING</b> </p> <p><b>PUBLICATION STATUS: PEER REVIEW JOURNAL</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim of study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>"to test the usefulness of ticlopidine in preventing stroke or death in patients at high risk, we undertook a randomized trial comparing ticlopidine and aspirin" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>"supported by Syntex Research, Palo Alto, Calif."</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"randomization within each center stratified on ... history of ischemic cardiovascular disease, the occurrence of a moderate or major stroke more than three months before entry, and the patient’s sex" "Maryland Medical Research Institute ... randomly assigned eligible patients" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"only the Maryland Medical Research Institute and an independent, external safety committee had access to the randomized code" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding (performance bias and detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"medications were suppIied in identical capsules and containers"</p> <p>"Blinded adjudicators ... classified alI end‐point events using standardized criteria drawn up <br> before the study" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"intention to treat analyses were performed"</p> <p>less than 3% loss to follow‐up</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Published protocol or registered trial document not available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Pharmaceutical funded</p> </td> </tr> </tbody> </table> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD005449-sec2-0023"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD005449-sec2-0022" class="jump-to">included studies</a></li> <li><a href="#CD005449-sec2-0024" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0009">Balsano 1990</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 6 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0010">CHANCE 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 3 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0011">CLARITY 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 30 days</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0012">COMMIT 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 30 days</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0013">CREDO 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Placebo group received clopidogrel for 30 days after PCI</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0014">Cun 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 6 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0015">Harrington 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 30 days</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0016">Ishikawa 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Observational trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0017">JUMBO TIMI 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 30 days</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0018">Li 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diabetes information not collected</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0019">Machraoui 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 3 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0020">MATCH 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ADP‐receptor inhibitor was not compared with alternative treatment or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0021">Mueller 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention for only 4 weeks</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0022">PLATO 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ADP‐receptor inhibitor is not compared with alternative treatment or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0023">STAMI 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 3 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0024">STIMS 1990</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diabetes patients on insulin excluded</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0025">TISS 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Follow‐up only 30 days</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0026">Tohgi 1987</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diabetes information not collected</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0027">TOPALS 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ADP‐receptor inhibitor was not compared with alternative treatment or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005449-bbs2-0028">TRITON‐TIMI 38 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ADP‐receptor inhibitor was not compared with alternative treatment or placebo</p> </td> </tr> </tbody> </table> </div> </p> </section> <section class="characteristicsOfOngoingStudies" lang=""> <div class="section-header" id="CD005449-sec2-0024"> <h3 class="title">Characteristics of ongoing studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD005449-sec2-0022" class="jump-to">included studies</a></li> <li><a href="#CD005449-sec2-0023" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">SPS3 2011 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Secondary Prevention of Small Subcortical Strokes (SPS3)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3000 patients with small subcortical strokes within the last 6 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clopidogrel and aspirin or aspirin and placebo</p> <p>Intensive or usual blood pressure treatment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Recurrent stroke, rate of cognitive decline and major vascular events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>February 2003</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>SPS3 Coordinating Centre</p> <p>UBC Department of Medicine | Division of Neurology</p> <p>S169‐2211 Wesbrook Mall, Vancouver, BC, V6T 2B5</p> <p>Phone: 604‐822‐1789</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD005449-sec1-0011"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD005449-tbl-0002"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">All‐cause mortality</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Ticlopidine vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005449-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-001-01.png?filename=nCD005449-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20All%E2%80%90cause%20mortality%2C%20Outcome%201%20Ticlopidine%20vs%20placebo.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD005449-fig-00101" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-001-01.png" alt="Comparison 1 All‐cause mortality, Outcome 1 Ticlopidine vs placebo."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 All‐cause mortality, Outcome 1 Ticlopidine vs placebo.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005449-tbl-0003"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Vascular mortality</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Ticlopidine vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005449-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-002-01.png?filename=nCD005449-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Vascular%20mortality%2C%20Outcome%201%20Ticlopidine%20vs%20placebo.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD005449-fig-00201" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-002-01.png" alt="Comparison 2 Vascular mortality, Outcome 1 Ticlopidine vs placebo."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Vascular mortality, Outcome 1 Ticlopidine vs placebo.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005449-tbl-0004"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">Stroke (fatal and non‐fatal)</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Ticlodipine vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005449-fig-00301"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-003-01.png?filename=nCD005449-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20Stroke%20%28fatal%20and%20non%E2%80%90fatal%29%2C%20Outcome%201%20Ticlodipine%20vs%20placebo.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.1</div> </div> <hr class="top"><img data-id="CD005449-fig-00301" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-01.png" alt="Comparison 3 Stroke (fatal and non‐fatal), Outcome 1 Ticlodipine vs placebo."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Stroke (fatal and non‐fatal), Outcome 1 Ticlodipine vs placebo.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Ticlodipine vs aspirin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005449-fig-00302"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-003-02.png?filename=nCD005449-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20Stroke%20%28fatal%20and%20non%E2%80%90fatal%29%2C%20Outcome%202%20Ticlodipine%20vs%20aspirin.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.2</div> </div> <hr class="top"><img data-id="CD005449-fig-00302" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-02.png" alt="Comparison 3 Stroke (fatal and non‐fatal), Outcome 2 Ticlodipine vs aspirin."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Stroke (fatal and non‐fatal), Outcome 2 Ticlodipine vs aspirin.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Clopidogrel vs aspirin &amp; dipyridamole <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005449-fig-00303"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-003-03.png?filename=nCD005449-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20Stroke%20%28fatal%20and%20non%E2%80%90fatal%29%2C%20Outcome%203%20Clopidogrel%20vs%20aspirin%20%26%20dipyridamole.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.3</div> </div> <hr class="top"><img data-id="CD005449-fig-00303" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-03.png" alt="Comparison 3 Stroke (fatal and non‐fatal), Outcome 3 Clopidogrel vs aspirin &amp; dipyridamole."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Stroke (fatal and non‐fatal), Outcome 3 Clopidogrel vs aspirin &amp; dipyridamole.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 ADP receptor antagonists vs other antiplatelet drug <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6340</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.81 [0.44, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005449-fig-00304"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-003-04.png?filename=nCD005449-CMP-003-04.ppt&amp;title=3.4&amp;caption=Comparison%203%20Stroke%20%28fatal%20and%20non%E2%80%90fatal%29%2C%20Outcome%204%20ADP%20receptor%20antagonists%20vs%20other%20antiplatelet%20drug.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.4</div> </div> <hr class="top"><img data-id="CD005449-fig-00304" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-04.png" alt="Comparison 3 Stroke (fatal and non‐fatal), Outcome 4 ADP receptor antagonists vs other antiplatelet drug."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Stroke (fatal and non‐fatal), Outcome 4 ADP receptor antagonists vs other antiplatelet drug. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005449-tbl-0005"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Myocardial infarction (fatal and non‐ fatal)</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Ticlopidine/Placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005449-fig-00401"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-004-01.png?filename=nCD005449-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20Myocardial%20infarction%20%28fatal%20and%20non%E2%80%90%20fatal%29%2C%20Outcome%201%20Ticlopidine%2FPlacebo.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.1</div> </div> <hr class="top"><img data-id="CD005449-fig-00401" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-004-01.png" alt="Comparison 4 Myocardial infarction (fatal and non‐ fatal), Outcome 1 Ticlopidine/Placebo."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 Myocardial infarction (fatal and non‐ fatal), Outcome 1 Ticlopidine/Placebo. </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD005449-fig-0001"> <img data-id="CD005449-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-AFig-FIG01.png" alt="Study flow diagram."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-AFig-FIG01.png?filename=nCD005449-AFig-FIG01.ppt&amp;title=1&amp;caption=Study%20flow%20diagram.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD005449-fig-0002"><img data-id="CD005449-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-AFig-FIG02.png" alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-AFig-FIG02.png?filename=nCD005449-AFig-FIG02.ppt&amp;title=2&amp;caption=Risk%20of%20bias%20graph%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20presented%20as%20percentages%20across%20all%20included%20studies.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD005449-fig-0003"><img data-id="CD005449-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-AFig-FIG03.png" alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-fig-0003" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-AFig-FIG03.png?filename=nCD005449-AFig-FIG03.ppt&amp;title=3&amp;caption=Risk%20of%20bias%20summary%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20for%20each%20included%20study.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-AFig-FIG03.png">Open in new tab</a></div> </div> <div class="figure" id="CD005449-fig-00101"><img data-id="CD005449-fig-00101" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-001-01.png" alt="Comparison 1 All‐cause mortality, Outcome 1 Ticlopidine vs placebo."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 All‐cause mortality, Outcome 1 Ticlopidine vs placebo.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-001-01.png?filename=nCD005449-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20All%E2%80%90cause%20mortality%2C%20Outcome%201%20Ticlopidine%20vs%20placebo.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD005449-fig-00201"><img data-id="CD005449-fig-00201" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-002-01.png" alt="Comparison 2 Vascular mortality, Outcome 1 Ticlopidine vs placebo."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Vascular mortality, Outcome 1 Ticlopidine vs placebo.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-002-01.png?filename=nCD005449-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Vascular%20mortality%2C%20Outcome%201%20Ticlopidine%20vs%20placebo.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD005449-fig-00301"><img data-id="CD005449-fig-00301" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-01.png" alt="Comparison 3 Stroke (fatal and non‐fatal), Outcome 1 Ticlodipine vs placebo."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Stroke (fatal and non‐fatal), Outcome 1 Ticlodipine vs placebo.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-fig-00301" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-003-01.png?filename=nCD005449-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20Stroke%20%28fatal%20and%20non%E2%80%90fatal%29%2C%20Outcome%201%20Ticlodipine%20vs%20placebo.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD005449-fig-00302"><img data-id="CD005449-fig-00302" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-02.png" alt="Comparison 3 Stroke (fatal and non‐fatal), Outcome 2 Ticlodipine vs aspirin."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Stroke (fatal and non‐fatal), Outcome 2 Ticlodipine vs aspirin.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-fig-00302" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-003-02.png?filename=nCD005449-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20Stroke%20%28fatal%20and%20non%E2%80%90fatal%29%2C%20Outcome%202%20Ticlodipine%20vs%20aspirin.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD005449-fig-00303"><img data-id="CD005449-fig-00303" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-03.png" alt="Comparison 3 Stroke (fatal and non‐fatal), Outcome 3 Clopidogrel vs aspirin &amp; dipyridamole."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Stroke (fatal and non‐fatal), Outcome 3 Clopidogrel vs aspirin &amp; dipyridamole.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-fig-00303" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-003-03.png?filename=nCD005449-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20Stroke%20%28fatal%20and%20non%E2%80%90fatal%29%2C%20Outcome%203%20Clopidogrel%20vs%20aspirin%20%26%20dipyridamole.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD005449-fig-00304"><img data-id="CD005449-fig-00304" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-04.png" alt="Comparison 3 Stroke (fatal and non‐fatal), Outcome 4 ADP receptor antagonists vs other antiplatelet drug."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Stroke (fatal and non‐fatal), Outcome 4 ADP receptor antagonists vs other antiplatelet drug. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-fig-00304" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-003-04.png?filename=nCD005449-CMP-003-04.ppt&amp;title=3.4&amp;caption=Comparison%203%20Stroke%20%28fatal%20and%20non%E2%80%90fatal%29%2C%20Outcome%204%20ADP%20receptor%20antagonists%20vs%20other%20antiplatelet%20drug.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-003-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD005449-fig-00401"><img data-id="CD005449-fig-00401" src="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-004-01.png" alt="Comparison 4 Myocardial infarction (fatal and non‐ fatal), Outcome 1 Ticlopidine/Placebo."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Myocardial infarction (fatal and non‐ fatal), Outcome 1 Ticlopidine/Placebo. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-fig-00401" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/ppt/CDSR/CD005449/image_n/nCD005449-CMP-004-01.png?filename=nCD005449-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20Myocardial%20infarction%20%28fatal%20and%20non%E2%80%90%20fatal%29%2C%20Outcome%201%20Ticlopidine%2FPlacebo.&amp;citation=Valentine N, Van de Laar FA, van Driel ML. Adenosine%E2%80%90diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, 11. Art. No.: CD005449. DOI: http://dx.doi.org/10.1002/14651858.CD005449.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005449.pub2/media/CDSR/CD005449/image_n/nCD005449-CMP-004-01.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD005449-tbl-0001" class="summary-of-findings framed"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Adenosine‐diphosphate (ADP) receptor antagonists (clopidogrel, ticlopidine, prasugrel, ticagrelor) for the prevention of cardiovascular disease in type 2 diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population: patients with type 2 diabetes mellitus</b> </p> <p><b>Settings: out‐patients</b> </p> <p><b>Intervention: ADP receptor antagonists</b> </p> <p><b>Comparison: Aspirin (/dipyramidole)/placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect <br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of Participants <br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence <br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Control</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>ADP receptor antagonist</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> <p>(ticlopidine vs placebo)</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>14.1%</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>17.4%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 1.29 (0.71 to 2.32)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>335 (1)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>moderate quality</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Vascular mortality</b> <br> (ticlopidine vs placebo) </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>11%</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>10.5%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.94 (0.47 to 1.88)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>335 (1)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>moderate quality</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Myocardial infarction (fatal and non‐fatal)</b> <br> (ticlopidine vs placebo) </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>11.7%</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>9.3%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.78 (0.39 to 1.57)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>335 (1)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>moderate quality</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Stroke (fatal and non‐fatal)</b> <br> (a. ticlopidine vs aspirin) <br> (b. clopidogrel vs aspirin &amp; dipyramidole) </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. 0.14%</p> <p>b. 0.11%</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>a. 0.9%</p> <p>b. 0.12%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. RR 0.56 (0.37 to 0.94)</p> <p>b. RR 1.12 (0.95 ‐ 1.32)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. 597 (1)</p> <p>b. 5770 (1)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. moderate quality</p> <p>b. moderate quality</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>a. See<sup>a</sup> </p> <p>b. See<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated for diabetes sub‐population</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated for diabetes sub‐population</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Costs</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not estimable</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>See comment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not investigated for diabetes sub‐population</p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence <br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Only one study with small number of participants providing data </p> <p><sup>b</sup>Unclear random sequence generation and high attrition rates </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005449-tbl-0006"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of study populations</span></div> <tbody> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Characteristic</b> </p> <p><b>Study ID</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention(s) and control(s)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] screened</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] randomised</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] ITT</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[n] finishing study</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>[%] of randomised participants <br> finishing study</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>AAASPS</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): Ticlopidine 250 mg bd (diabetes patients)</p> <p>C(d): Aspirin 325 mg bd (diabetes patients)</p> <p>I(t): Ticlopidine 250 mg bd (all patients)</p> <p>C(t): Aspirin 325 mg bd (all patients)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 359</p> <p>C(d): 379</p> <p>I(t): 902</p> <p>C(t): 907</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 359</p> <p>C(d): 379</p> <p>I(t): 902</p> <p>C(t): 907</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 626</p> <p>C(t): 661</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 69.4</p> <p>C(t): 72.9</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAPRIE</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): Clopidogrel 75 mg daily (diabetes patients)</p> <p>C(d): Aspirin 325 mg daily (diabetes patients)</p> <p>I(t): Clopidogrel 75 mg daily (all patients)</p> <p>C(t): Aspirin 325 mg daily (all patients)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 20%</p> <p>C(d): 20%</p> <p>I(t): 9599</p> <p>C(t): 9586</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 20% (1920)</p> <p>C(d): 20% (1917)</p> <p>I(t): 9599</p> <p>C(t): 9586</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 9577</p> <p>C(t): 9566</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 99.8</p> <p>C(t): 99.8</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CATS</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): Ticlopidine 250 mg bd (diabetes patients)</p> <p>C(d): Placebo (diabetes patients)</p> <p>I(t): Ticlopidine 250 mg bd (all patients)</p> <p>C(t): Placebo (all patients)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 172</p> <p>C(d): 163</p> <p>I(t): 525</p> <p>C(t): 528</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 172</p> <p>C(d): 163</p> <p>I(t): 519</p> <p>C(t): 515</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 287</p> <p>C(t): 364</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 54.7</p> <p>C(t): 68.9</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CHARISMA</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): Clopidogrel 75 mg daily and aspirin 75 to 162 mg daily (diabetes patients)</p> <p>C(d): Aspirin 75 to 162 mg daily (diabetes patients)</p> <p>I(t): Clopidogrel 75 mg daily and aspirin 75 to 162 mg daily (all patients)</p> <p>C(t): Aspirin 75 to 162 mg daily (all patients)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 3304</p> <p>C(d): 3252</p> <p>I(t): 7802</p> <p>C(t): 7801</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 3304</p> <p>C(d): 3252</p> <p>I(t): 7802</p> <p>C(t): 7801</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 79.6%</p> <p>C(t): 81.8%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 79.6</p> <p>C(t): 81.8</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CURE</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): Clopidogrel 75 mg daily and aspirin 75 to 300 mg daily (diabetes patients)</p> <p>C(d): Aspirin 75 to 300 mg daily (diabetes patients)</p> <p>I(t): Clopidogrel 75 mg daily and aspirin 75 to 300 mg daily (all patients)</p> <p>C(t): Aspirin 75 to 300 mg daily (all patients)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 1405</p> <p>C(d): 1435</p> <p>I(t): 6259</p> <p>C(t): 6303</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 1405</p> <p>C(d): 1435</p> <p>I(t): 6259</p> <p>C(t): 6303</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 78.9%</p> <p>C(t): 81.2%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 78.9</p> <p>C(t): 81.2</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Park</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): Clopidogrel 75 mg daily and aspirin 100 to 200 mg daily (diabetes patients)</p> <p>C(d): Aspirin 100 to 200 mg daily (diabetes patients)</p> <p>I(t): Clopidogrel 75 mg daily and aspirin 100 to 200 mg daily (all patients)</p> <p>C(t): Aspirin 100 to 200 mg daily (all patients)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 340</p> <p>C(d): 364</p> <p>I(t): 1357</p> <p>C(t): 1344</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 327</p> <p>C(t): 313</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>PRoFESS</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): Clopidogrel 75 mg daily (diabetes patients)</p> <p>C(d): Aspirin/dipyridamole 25 mg/200 mg bd (diabetes patients)</p> <p>I(t): Clopidogrel 75 mg daily (all patients)</p> <p>C(t): Aspirin/dipyridamole 25 mg/200 mg bd (all patients)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 2840</p> <p>C(d): 2903</p> <p>I(t): 10.151</p> <p>C(t): 10.181</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 2840</p> <p>C(d): 2903</p> <p>I(t): 10.151</p> <p>C(t): 10.181</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 7736</p> <p>C(t): 7095</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 76.2</p> <p>C(t): 69.7</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>TASS</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): Ticlopidine 250 mg bd (diabetes patients)</p> <p>C(d): Aspirin 650 mg bd (diabetes patients)</p> <p>I(t): Ticlopidine 250 mg bd (all patients)</p> <p>C(t): Aspirin 650 mg bd (all patients)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): 291</p> <p>C(d): 306</p> <p>I(t): 1529</p> <p>C(t): 1540</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 1529</p> <p>C(t): 1540</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 828</p> <p>C(t): 941</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>I(d): ‐</p> <p>C(d): ‐</p> <p>I(t): 54.2</p> <p>C(t): 61.1</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>Total</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>All interventions (diabetes patients)</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>8711 (and CAPRIE participants)</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>All controls (diabetes patients)</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>8802 (and CAPRIE participants)</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>All interventions (all patients)</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>38,124</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>All controls (all patients)</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>38,190</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>All interventions and controls (diabetes patients)</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>21,379</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>All interventions and controls (all patients)</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b><i>76,314</i> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>"‐" denotes not reported</p> <p>Abbreviations:</p> <p>bd: twice daily; C: control; C(d): intervention (diabetes patients); C(t): intervention (all patients); I: intervention; I(d): intervention (diabetes patients); I(t): intervention (all patients); ITT: intention‐to‐treat </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of study populations</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/full#CD005449-tbl-0006" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005449-tbl-0002" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">All‐cause mortality</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Ticlopidine vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">All‐cause mortality</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005449-tbl-0003" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Vascular mortality</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Ticlopidine vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Vascular mortality</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-tbl-0003" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005449-tbl-0004" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">Stroke (fatal and non‐fatal)</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Ticlodipine vs placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Ticlodipine vs aspirin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Clopidogrel vs aspirin &amp; dipyridamole <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 ADP receptor antagonists vs other antiplatelet drug <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6340</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.81 [0.44, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">Stroke (fatal and non‐fatal)</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-tbl-0004" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005449-tbl-0005" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Myocardial infarction (fatal and non‐ fatal)</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Ticlopidine/Placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Myocardial infarction (fatal and non‐ fatal)</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005449.pub2/references#CD005449-tbl-0005" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005449-note-1207">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD005449-note-1206">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD005449-note-1205">日本語</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1581423095000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581423095000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717777000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717709000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717714000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005449\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005449\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005449\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005449\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005449\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581423095000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005449.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005449.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD005449.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD005449.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005449.pub2%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583237590163" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583237590167" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005449&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD005449.pub2";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 